| C025205 | 1,10-phenanthroline | "[Copper binds to phthalic acid binds to 1,10-phenanthroline] which results in increased expression of H2AFX protein modified form" | 22659117 |
| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of H2AFX mRNA" | 28903501 |
| C033020 | 1-aminobenzotriazole | 1-aminobenzotriazole inhibits the reaction [propylene dichloride results in increased phosphorylation of H2AFX protein] | 28300663 |
| C108731 | 1'-(hydroxymethyl)eugenol | 1'-(hydroxymethyl)eugenol results in increased expression of H2AFX protein | 26542539 |
| C051246 | 1-methylanthracene | [1-methylanthracene co-treated with fluoranthene] results in decreased expression of H2AFX mRNA | 28329830 |
| C078765 | 2,3,5-(triglutathion-S-yl)hydroquinone | "2,3,5-(triglutathion-S-yl)hydroquinone results in increased phosphorylation of H2AFX protein" | 21135414 |
| C078765 | 2,3,5-(triglutathion-S-yl)hydroquinone | "Acetylcysteine inhibits the reaction [2,3,5-(triglutathion-S-yl)hydroquinone results in increased phosphorylation of H2AFX protein]" | 21135414 |
| C029497 | 2,3-bis(3'-hydroxybenzyl)butyrolactone | "[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of H2AFX mRNA" | 19167446 |
| C063002 | 2,3-dimethoxy-1,4-naphthoquinone | "2,3-dimethoxy-1,4-naphthoquinone results in increased expression of H2AFX mRNA" | 19031421 |
| C010914 | 2,4-diaminotoluene | "2,4-diaminotoluene results in decreased expression of H2AFX mRNA" | 20713471 |
| C117776 | 2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone | "2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone analog results in increased expression of H2AFX protein modified form" | 26630137 |
| C015802 | 2,6-dichloro-4-nitrophenol | "2,6-dichloro-4-nitrophenol results in decreased expression of H2AFX mRNA" | 11227219 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of H2AFX protein modified form" | 28160022 |
| C036989 | 2-amino-3,4-dimethylimidazo(4,5-f)quinoline | "2-amino-3,4-dimethylimidazo(4,5-f)quinoline results in increased expression of H2AFX protein modified form" | 28160022 |
| C036990 | 2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline | "2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of H2AFX protein modified form" | 28160022 |
| C017821 | 2-amino-3-methyl-9H-pyrido(2,3-b)indole | "2-amino-3-methyl-9H-pyrido(2,3-b)indole results in increased expression of H2AFX protein modified form" | 28160022 |
| C029216 | 2-amino-3-methylimidazo(4,5-f)quinoline | "2-amino-3-methylimidazo(4,5-f)quinoline results in increased expression of H2AFX protein modified form" | 28160022 |
| C432523 | 2-amino-3-methylimidazo(4,5-f)quinoxaline | "2-amino-3-methylimidazo(4,5-f)quinoxaline results in increased expression of H2AFX protein modified form" | 28160022 |
| C023785 | 2-amino-6-methyldipyrido(1,2-a-3',2'-d)imidazole | "2-amino-6-methyldipyrido(1,2-a-3',2'-d)imidazole results in increased expression of H2AFX protein modified form" | 28160022 |
| C017822 | 2-amino-9H-pyrido(2,3-b)indole | "2-amino-9H-pyrido(2,3-b)indole results in increased expression of H2AFX protein modified form" | 28160022 |
| C031278 | 2-chloroethyl ethyl sulfide | 2-chloroethyl ethyl sulfide results in increased expression of H2AFX protein modified form | 20840853 |
| C031278 | 2-chloroethyl ethyl sulfide | 2-chloroethyl ethyl sulfide results in increased phosphorylation of H2AFX protein | 21722719 |
| C031278 | 2-chloroethyl ethyl sulfide | Glutathione inhibits the reaction [2-chloroethyl ethyl sulfide results in increased phosphorylation of H2AFX protein] | 21722719 |
| C022830 | 2-methoxyestradiol | 2-methoxyestradiol results in increased expression of H2AFX protein modified form | 23967052 |
| C511621 | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide results in decreased expression of H2AFX protein modified form | 26651356 |
| C495818 | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of H2AFX protein] | 26231820 |
| C495818 | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [propylene dichloride results in increased phosphorylation of H2AFX protein] | 28300663 |
| C495818 | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [T-2 Toxin results in increased activity of H2AFX protein] | 20150440 |
| C495818 | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one promotes the reaction [Flavanones results in increased phosphorylation of H2AFX protein] | 21616090 |
| C495818 | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one results in decreased phosphorylation of H2AFX protein | 23227178 |
| C495818 | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one | 2-(morpholin-4-yl)benzo(h)chromen-4-one promotes the reaction [2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one results in decreased phosphorylation of H2AFX protein] | 23227178 |
| C495818 | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one | bisphenol A promotes the reaction [2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one results in decreased phosphorylation of H2AFX protein] | 23227178 |
| C495818 | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [arsenic trioxide results in increased expression of H2AFX protein] | 23337567 |
| C479235 | 2-(morpholin-4-yl)benzo(h)chromen-4-one | 2-(morpholin-4-yl)benzo(h)chromen-4-one promotes the reaction [2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one results in decreased phosphorylation of H2AFX protein] | 23227178 |
| C005328 | 2-nitroanisole | 2-nitroanisole results in increased expression of H2AFX protein | 26338220 |
| C019499 | 2-nitrofluorene | 2-nitrofluorene results in increased expression of H2AFX mRNA | 15890375 |
| C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone inhibits the reaction [ferrous sulfate results in increased expression of H2AFX protein] | 28583816 |
| C045421 | 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine | "3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in increased expression of H2AFX protein modified form" | 28160022 |
| C472791 | 3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid | 3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid analog results in increased phosphorylation of H2AFX protein | 17512204 |
| C019132 | 3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole | "3-amino-1,4-dimethyl-5H-pyrido(4,3-b)indole results in increased expression of H2AFX protein modified form" | 28160022 |
| C019133 | 3-amino-1-methyl-5H-pyrido(4,3-b)indole | "3-amino-1-methyl-5H-pyrido(4,3-b)indole results in increased expression of H2AFX protein modified form" | 28160022 |
| C560580 | 3-amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide | 3-amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide inhibits the reaction [Camptothecin results in increased expression of H2AFX protein modified form] | 25269479 |
| C560580 | 3-amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide | 3-amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide inhibits the reaction [NSC 724998 results in increased expression of H2AFX protein modified form] | 25269479 |
| C078157 | 3-aminopyridine-2-carboxaldehyde thiosemicarbazone | 3-aminopyridine-2-carboxaldehyde thiosemicarbazone results in increased expression of H2AFX protein | 25130544 |
| C017906 | 3-dinitrobenzene | 3-dinitrobenzene results in decreased expression of H2AFX mRNA | 21983209 |
| C000614725 | 3'-oxomethylisoeugenol | 3'-oxomethylisoeugenol results in increased expression of H2AFX protein | 26542539 |
| C070899 | 4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione | "4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione inhibits the reaction [Doxorubicin results in increased expression of H2AFX protein]" | 17875725 |
| C070899 | 4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione | "4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione inhibits the reaction [Etoposide results in increased expression of H2AFX protein]" | 17875725 |
| C090942 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [resveratrol results in increased phosphorylation of H2AFX protein] | 25619392 |
| C090942 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Etoposide results in increased expression of H2AFX protein] | 20643100 |
| C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in increased phosphorylation of H2AFX protein | 22331492 |
| C027576 | 4-hydroxy-2-nonenal | POLH protein affects the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of H2AFX protein] | 22331492 |
| C027576 | 4-hydroxy-2-nonenal | POLK protein affects the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of H2AFX protein] | 22331492 |
| C027576 | 4-hydroxy-2-nonenal | POLL protein affects the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of H2AFX protein] | 22331492 |
| C027576 | 4-hydroxy-2-nonenal | REV1 protein affects the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of H2AFX protein] | 22331492 |
| C027576 | 4-hydroxy-2-nonenal | REV3L protein affects the reaction [4-hydroxy-2-nonenal results in increased phosphorylation of H2AFX protein] | 22331492 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of H2AFX protein] | 26231820 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased phosphorylation of H2AFX protein | 21882252 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of H2AFX protein | 26231820 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | Caffeine inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of H2AFX protein] | 26231820 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased phosphorylation of H2AFX protein] | 21882252 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | CYP2A13 protein promotes the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of H2AFX protein] | 26231820 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of H2AFX mRNA | 15890375 |
| C558288 | 5-methylselenylmethyl-2'-deoxyuridine | 5-methylselenylmethyl-2'-deoxyuridine results in increased phosphorylation of H2AFX protein | 22002103 |
| C558289 | 5-phenylselenylmethyl-2'-deoxyuridine | 5-phenylselenylmethyl-2'-deoxyuridine results in increased phosphorylation of H2AFX protein | 22002103 |
| C571532 | 6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid | 6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid results in increased expression of H2AFX protein | 25316768 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine results in increased phosphorylation of H2AFX protein" | 23274516 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "Acetylcysteine inhibits the reaction [(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine results in increased phosphorylation of H2AFX protein]" | 23274516 |
| C093792 | 680C91 | 680C91 results in decreased expression of H2AFX protein modified form | 26651356 |
| C421010 | 9-(4'-aminophenyl)-9H-pyrido(3,4-b)indole | "9-(4'-aminophenyl)-9H-pyrido(3,4-b)indole results in increased expression of H2AFX protein modified form" | 28160022 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of H2AFX mRNA | 25458485 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of H2AFX mRNA | 21420995|2223033 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of H2AFX mRNA | 17562736 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of H2AFX protein | 26011634 |
| C487680 | acetylbritannilatone | acetylbritannilatone analog results in increased expression of H2AFX protein | 27262408 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Sulindac promotes the reaction [Bortezomib results in increased phosphorylation of H2AFX protein]] | 16033843 |
| D000111 | Acetylcysteine | "Acetylcysteine inhibits the reaction [2,3,5-(triglutathion-S-yl)hydroquinone results in increased phosphorylation of H2AFX protein]" | 21135414 |
| D000111 | Acetylcysteine | "Acetylcysteine inhibits the reaction [(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine results in increased phosphorylation of H2AFX protein]" | 23274516 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [alpha-terthienylmethanol results in increased phosphorylation of H2AFX protein] | 28506552 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [[Bortezomib co-treated with romidepsin] results in increased phosphorylation of H2AFX protein] | 15173094 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [cobaltous chloride promotes the reaction [nickel chloride results in increased phosphorylation of H2AFX protein]] | 22172632 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of H2AFX protein] | 22172632 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Doxorubicin results in increased phosphorylation of H2AFX protein] | 15489221 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [[fludarabine co-treated with LAQ824] results in increased expression of H2AFX protein] | 18852132 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of H2AFX protein] | 28300663 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [LAQ824 results in increased expression of H2AFX protein] | 18852132 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [manumycin results in increased phosphorylation of H2AFX protein] | 19409983 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [nickel chloride promotes the reaction [cobaltous chloride results in increased phosphorylation of H2AFX protein]] | 22172632 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [nickel chloride results in increased phosphorylation of H2AFX protein] | 22172632 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [PCB 180 metabolite results in increased phosphorylation of H2AFX protein] | 26148434 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [propylene dichloride results in increased phosphorylation of H2AFX protein] | 28300663 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [erythritol anhydride results in increased expression of H2AFX protein modified form] | 25633853 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased activity of H2AFX protein] | 24614525 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [tributyltin results in increased expression of H2AFX protein modified form] | 26079211 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased phosphorylation of H2AFX protein | 28882572 |
| D016604 | Aflatoxin B1 | AHR protein affects the reaction [Aflatoxin B1 results in increased phosphorylation of H2AFX protein] | 28882572 |
| D016604 | Aflatoxin B1 | ARNT protein affects the reaction [Aflatoxin B1 results in increased phosphorylation of H2AFX protein] | 28882572 |
| D016604 | Aflatoxin B1 | TP53 protein affects the reaction [Aflatoxin B1 results in increased phosphorylation of H2AFX protein] | 28882572 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased phosphorylation of H2AFX protein | 19770486 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased expression of H2AFX mRNA | 15890375 |
| C027955 | aflatoxin G1 | aflatoxin G1 results in increased expression of H2AFX protein modified form | 23907605 |
| C027955 | aflatoxin G1 | Methoxsalen inhibits the reaction [aflatoxin G1 results in increased expression of H2AFX protein modified form] | 23907605 |
| C027955 | aflatoxin G1 | Nicotine inhibits the reaction [aflatoxin G1 results in increased expression of H2AFX protein modified form] | 23907605 |
| D000393 | Air Pollutants | Air Pollutants results in increased phosphorylation of H2AFX protein | 23159502 |
| C000607033 | alpha-terthienylmethanol | Acetylcysteine inhibits the reaction [alpha-terthienylmethanol results in increased phosphorylation of H2AFX protein] | 28506552 |
| C000607033 | alpha-terthienylmethanol | alpha-terthienylmethanol results in increased phosphorylation of H2AFX protein | 28506552 |
| D024502 | alpha-Tocopherol | alpha-Tocopherol inhibits the reaction [Sulindac promotes the reaction [Bortezomib results in increased phosphorylation of H2AFX protein]] | 16033843 |
| C005197 | alternariol | alternariol results in increased expression of H2AFX protein modified form | 26341179 |
| C077990 | alvocidib | alvocidib affects the expression of H2AFX protein | 15078984 |
| D000585 | Aminacrine | Aminacrine results in decreased phosphorylation of H2AFX protein | 26928355 |
| D000585 | Aminacrine | [Aminacrine results in decreased phosphorylation of H2AFX protein] inhibits the reaction [Camptothecin results in increased activity of and affects the localization of MDC1 protein] | 26928355 |
| C413760 | aminoflavone | aminoflavone results in increased expression of H2AFX protein | 24885022 |
| D000872 | Anthocyanins | Anthocyanins results in increased phosphorylation of H2AFX protein | 27444805 |
| D018906 | Antineoplastic Agents, Alkylating | "Antineoplastic Agents, Alkylating results in increased expression of H2AFX protein" | 21500194 |
| D016590 | Aphidicolin | Aphidicolin inhibits the reaction [docetaxel results in increased expression of H2AFX protein] | 20878124 |
| C006632 | arsenic trioxide | [arsenic trioxide co-treated with Sulindac] results in increased phosphorylation of H2AFX protein | 18636201 |
| C006632 | arsenic trioxide | arsenic trioxide inhibits the reaction [SHH protein inhibits the reaction [Cisplatin results in increased phosphorylation of H2AFX protein]] | 23861973 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of H2AFX protein modified form | 28265077|2831838 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased phosphorylation of H2AFX protein | 16891316|2386197 |
| C006632 | arsenic trioxide | MUS81 protein mutant form inhibits the reaction [arsenic trioxide results in increased expression of H2AFX protein modified form] | 28318385 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of H2AFX protein modified form | 28265077 |
| C006632 | arsenic trioxide | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [arsenic trioxide results in increased expression of H2AFX protein] | 23337567 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of H2AFX protein | 23337567 |
| D001205 | Ascorbic Acid | [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of H2AFX mRNA | 26424790 |
| D001205 | Ascorbic Acid | [Ascorbic Acid results in increased reduction of Vitamin K 3] which results in increased phosphorylation of H2AFX protein | 19482829 |
| D001241 | Aspirin | Aspirin results in decreased expression of H2AFX protein | 23363784 |
| D001280 | Atrazine | Atrazine affects the expression of H2AFX protein modified form | 26518232 |
| D001374 | Azacitidine | Azacitidine results in increased expression of H2AFX protein | 17991895 |
| D001374 | Azacitidine | Azacitidine inhibits the reaction [potassium bromate results in increased phosphorylation of H2AFX protein] | 25015661 |
| D001379 | Azathioprine | Azathioprine results in decreased expression of H2AFX mRNA | 22623647 |
| D001554 | Benzene | Benzene results in increased expression of H2AFX mRNA | 15120971|1512265 |
| C043931 | benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide-DNA | "benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide-DNA results in increased phosphorylation of H2AFX protein" | 18848825 |
| C072019 | benzo(a)pyrene diolepoxide I | benzo(a)pyrene diolepoxide I results in increased expression of H2AFX protein modified form | 27694624 |
| D001564 | Benzo(a)pyrene | [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased phosphorylation of H2AFX protein | 21882252 |
| D001564 | Benzo(a)pyrene | ARNT protein affects the reaction [Benzo(a)pyrene results in increased phosphorylation of H2AFX protein] | 28882572 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of H2AFX protein | 21873372 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of H2AFX protein modified form | 26657896 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased phosphorylation of H2AFX protein | 20888899|2238920 |
| D001564 | Benzo(a)pyrene | Caffeine promotes the reaction [Benzo(a)pyrene results in increased phosphorylation of H2AFX protein] | 20888899 |
| D001564 | Benzo(a)pyrene | Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased phosphorylation of H2AFX protein] | 21882252 |
| D001564 | Benzo(a)pyrene | PCB 180 metabolite promotes the reaction [Benzo(a)pyrene results in increased phosphorylation of H2AFX protein] | 26148434 |
| D001564 | Benzo(a)pyrene | TP53 protein affects the reaction [Benzo(a)pyrene results in increased phosphorylation of H2AFX protein] | 28882572 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased phosphorylation of H2AFX protein | 19770486 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased phosphorylation of H2AFX protein" | 24743697 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the phosphorylation of H2AFX protein" | 18848825 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of H2AFX mRNA" | 20382639 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of H2AFX mRNA" | 19150397 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "[Hydrogen Peroxide co-treated with 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide] results in increased phosphorylation of H2AFX protein" | 18848825 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased phosphorylation of H2AFX protein" | 22331492 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "POLH protein affects the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased phosphorylation of H2AFX protein]" | 22331492 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "REV1 protein affects the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased phosphorylation of H2AFX protein]" | 22331492 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "REV3L protein affects the reaction [7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased phosphorylation of H2AFX protein]" | 22331492 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [veliparib promotes the reaction [Camptothecin results in increased expression of H2AFX protein]] | 21227924 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Doxorubicin results in increased expression of H2AFX protein] | 17875725 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Etoposide results in increased expression of H2AFX protein] | 17875725 |
| C517629 | benzyloxycarbonyl-valyl-alanyl-aspartic acid | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Fluorouracil co-treated with olaparib] results in increased phosphorylation of H2AFX protein] | 26544897 |
| C517629 | benzyloxycarbonyl-valyl-alanyl-aspartic acid | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[TNF protein co-treated with trovafloxacin] results in increased expression of H2AFX protein modified form] | 25748550 |
| C517629 | benzyloxycarbonyl-valyl-alanyl-aspartic acid | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [trovafloxacin results in increased expression of H2AFX protein modified form] | 25748550 |
| C517629 | benzyloxycarbonyl-valyl-alanyl-aspartic acid | TP53 gene mutant form affects the reaction [benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Fluorouracil co-treated with olaparib] results in increased phosphorylation of H2AFX protein]] | 26544897 |
| D001599 | Berberine | Berberine results in decreased expression of H2AFX mRNA | 27311644 |
| D001599 | Berberine | Berberine results in decreased expression of H2AFX protein | 23363784 |
| D001599 | Berberine | Berberine results in increased expression of H2AFX protein modified form | 23747414 |
| D001599 | Berberine | TOP2A protein affects the reaction [Berberine results in increased expression of H2AFX protein modified form] | 23747414 |
| D004958 | Estradiol | Estradiol promotes the reaction [PCB 180 metabolite results in increased phosphorylation of H2AFX protein] | 26148434 |
| D004958 | Estradiol | Estradiol results in increased expression of H2AFX mRNA | 16474171|1916744 |
| D004958 | Estradiol | Estradiol results in increased expression of H2AFX protein | 16462019 |
| D004958 | Estradiol | Estradiol results in increased expression of H2AFX protein modified form | 25933419 |
| D004958 | Estradiol | Estradiol results in increased expression of H2AFX protein | 23788033 |
| D004958 | Estradiol | fulvestrant inhibits the reaction [Estradiol results in increased expression of H2AFX protein] | 23788033 |
| C031463 | beta-glycerophosphoric acid | [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of H2AFX mRNA | 26424790 |
| D015082 | 2,2'-Dipyridyl | "[Copper binds to phthalic acid binds to 2,2'-Dipyridyl] which results in increased expression of H2AFX protein modified form" | 22659117 |
| C006780 | bisphenol A | bisphenol A promotes the reaction [2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one results in decreased phosphorylation of H2AFX protein] | 23227178 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of H2AFX mRNA | 29275510 |
| C006780 | bisphenol A | bisphenol A results in increased expression of H2AFX mRNA | 16474171 |
| C006780 | bisphenol A | bisphenol A results in increased expression of H2AFX protein | 16462019|2927551 |
| C006780 | bisphenol A | bisphenol A results in increased expression of H2AFX protein modified form | 25933419 |
| C006780 | bisphenol A | MYC protein promotes the reaction [bisphenol A results in increased expression of H2AFX protein modified form] | 25933419 |
| C006780 | bisphenol A | bisphenol A inhibits the reaction [[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] which results in increased expression of H2AFX protein] | 25693136 |
| C006780 | bisphenol A | [bisphenol A co-treated with Testosterone] results in increased expression of H2AFX mRNA | 26496021 |
| C006780 | bisphenol A | bisphenol A results in increased expression of H2AFX protein | 23788033 |
| C006780 | bisphenol A | fulvestrant inhibits the reaction [bisphenol A results in increased expression of H2AFX protein] | 23788033 |
| C000611646 | bisphenol F | bisphenol F results in increased expression of H2AFX protein | 29102535 |
| D001761 | Bleomycin | Bleomycin results in increased expression of H2AFX protein | 25130544 |
| C000591165 | BO-1012 | BO-1012 results in increased expression of H2AFX protein | 24823293 |
| C557045 | BO-1051 | BO-1051 results in increased expression of H2AFX protein modified form | 21184746 |
| D000069286 | Bortezomib | Acetylcysteine inhibits the reaction [Sulindac promotes the reaction [Bortezomib results in increased phosphorylation of H2AFX protein]] | 16033843 |
| D000069286 | Bortezomib | alpha-Tocopherol inhibits the reaction [Sulindac promotes the reaction [Bortezomib results in increased phosphorylation of H2AFX protein]] | 16033843 |
| D000069286 | Bortezomib | Sulindac promotes the reaction [Bortezomib results in increased phosphorylation of H2AFX protein] | 16033843 |
| D000069286 | Bortezomib | Acetylcysteine inhibits the reaction [[Bortezomib co-treated with romidepsin] results in increased phosphorylation of H2AFX protein] | 15173094 |
| D000069286 | Bortezomib | [Bortezomib co-treated with romidepsin] results in increased phosphorylation of H2AFX protein | 15173094 |
| D000069286 | Bortezomib | Bortezomib results in increased expression of H2AFX protein modified form | 16778179|1879076 |
| D000069286 | Bortezomib | leptomycin B promotes the reaction [Bortezomib results in increased expression of H2AFX protein modified form] | 16778179 |
| D000069286 | Bortezomib | Bortezomib inhibits the reaction [Doxorubicin results in increased expression of H2AFX protein] | 17875725 |
| D000069286 | Bortezomib | Bortezomib inhibits the reaction [Etoposide results in increased expression of H2AFX protein] | 17875725 |
| D000069286 | Bortezomib | Bortezomib results in increased expression of H2AFX protein | 20028860 |
| D001959 | Bromates | Bromates results in increased phosphorylation of H2AFX protein | 21864635 |
| D001959 | Bromates | chlorite promotes the reaction [Bromates results in increased phosphorylation of H2AFX protein] | 21864635 |
| D002066 | Busulfan | Busulfan results in increased phosphorylation of H2AFX protein | 18339423 |
| D002066 | Busulfan | [clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased expression of H2AFX protein | 20933509 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased phosphorylation of H2AFX protein | 24743697 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in decreased expression of H2AFX mRNA | 15336504 |
| D002085 | Butylhydroxybutylnitrosamine | Butylhydroxybutylnitrosamine results in increased expression of H2AFX protein | 26338220 |
| D020148 | Butyric Acid | Butyric Acid results in decreased expression of H2AFX mRNA | 12800193 |
| D020148 | Butyric Acid | Butyric Acid results in increased expression of H2AFX protein | 25070040 |
| C584509 | C646 compound | C646 compound results in decreased expression of H2AFX mRNA | 26191083 |
| C584509 | C646 compound | C646 compound results in decreased phosphorylation of H2AFX protein | 23698071 |
| D002104 | Cadmium | Cadmium results in increased expression of H2AFX protein | 27658547 |
| D019256 | Cadmium Chloride | Cadmium Chloride affects the expression of H2AFX mRNA | 18974090 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased phosphorylation of H2AFX protein | 20435356 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of H2AFX protein | 22457795 |
| D002110 | Caffeine | Caffeine inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of H2AFX protein] | 26231820 |
| D002110 | Caffeine | Caffeine inhibits the reaction [resveratrol results in increased phosphorylation of H2AFX protein] | 15975956 |
| D002110 | Caffeine | Caffeine inhibits the reaction [riccardin D results in increased phosphorylation of H2AFX protein] | 24069304 |
| D002110 | Caffeine | Caffeine inhibits the reaction [silybin results in increased phosphorylation of H2AFX protein] | 16777994 |
| D002110 | Caffeine | Caffeine promotes the reaction [Benzo(a)pyrene results in increased phosphorylation of H2AFX protein] | 20888899 |
| D002110 | Caffeine | [Caffeine co-treated with Ephedrine] results in increased phosphorylation of H2AFX protein | 15537744 |
| D002166 | Camptothecin | 3-amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide inhibits the reaction [Camptothecin results in increased expression of H2AFX protein modified form] | 25269479 |
| D002166 | Camptothecin | [Aminacrine results in decreased phosphorylation of H2AFX protein] inhibits the reaction [Camptothecin results in increased activity of and affects the localization of MDC1 protein] | 26928355 |
| D002166 | Camptothecin | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [veliparib promotes the reaction [Camptothecin results in increased expression of H2AFX protein]] | 21227924 |
| D002166 | Camptothecin | Camptothecin results in increased expression of H2AFX protein | 21227924|2230203 |
| D002166 | Camptothecin | Camptothecin results in increased expression of H2AFX protein modified form | 25269479|2577243 |
| D002166 | Camptothecin | Camptothecin results in increased phosphorylation of H2AFX protein | 21646468 |
| D002166 | Camptothecin | ERCC1 protein promotes the reaction [veliparib promotes the reaction [Camptothecin results in increased expression of H2AFX protein]] | 21227924 |
| D002166 | Camptothecin | ERCC4 protein promotes the reaction [veliparib promotes the reaction [Camptothecin results in increased expression of H2AFX protein]] | 21227924 |
| D002166 | Camptothecin | H2AFX gene mutant form inhibits the reaction [MIR138-1 results in increased susceptibility to Camptothecin] | 21693595 |
| D002166 | Camptothecin | [MIR138-1 results in decreased expression of H2AFX] which results in increased susceptibility to Camptothecin | 21693595 |
| D002166 | Camptothecin | palbociclib inhibits the reaction [Camptothecin results in increased expression of H2AFX protein] | 22302033 |
| D002166 | Camptothecin | PPP2R2A protein inhibits the reaction [Camptothecin results in increased expression of H2AFX protein modified form] | 25772433 |
| D002166 | Camptothecin | PPP2R5C protein promotes the reaction [Camptothecin results in increased expression of H2AFX protein modified form] | 25772433 |
| D002166 | Camptothecin | PPP2R5E protein inhibits the reaction [Camptothecin results in increased expression of H2AFX protein modified form] | 25772433 |
| D002166 | Camptothecin | [Propyl Gallate results in decreased phosphorylation of H2AFX protein] inhibits the reaction [Camptothecin results in increased activity of and affects the localization of MDC1 protein] | 26928355 |
| D002166 | Camptothecin | TDP1 protein inhibits the reaction [Camptothecin results in increased expression of H2AFX protein] | 21227924 |
| D002166 | Camptothecin | TDP1 protein inhibits the reaction [veliparib promotes the reaction [Camptothecin results in increased expression of H2AFX protein]] | 21227924 |
| D002166 | Camptothecin | veliparib promotes the reaction [Camptothecin results in increased expression of H2AFX protein] | 21227924 |
| D002166 | Camptothecin | Camptothecin results in increased expression of H2AFX protein | 17875725 |
| D002166 | Camptothecin | Camptothecin results in increased expression of H2AFX protein | 17875725 |
| D002211 | Capsaicin | Capsaicin results in increased localization of H2AFX protein | 22226932 |
| D002219 | Carbamates | Carbamates analog results in increased phosphorylation of and results in increased activity of H2AFX protein | 19376255 |
| D002219 | Carbamates | Carbamates analog results in increased phosphorylation of H2AFX protein | 19111005 |
| C524865 | carfilzomib | [carfilzomib co-treated with vorinostat] results in increased expression of H2AFX protein | 20233973 |
| D002330 | Carmustine | Carmustine affects the localization of H2AFX protein | 20472715 |
| D002330 | Carmustine | Carmustine results in decreased expression of H2AFX mRNA | 15980968 |
| D002330 | Carmustine | Carmustine results in increased phosphorylation of H2AFX protein | 20472715 |
| D002330 | Carmustine | MDM4 protein promotes the reaction [Carmustine affects the localization of H2AFX protein] | 20472715 |
| D002330 | Carmustine | MDM4 protein promotes the reaction [Carmustine results in increased phosphorylation of H2AFX protein] | 20472715 |
| D002392 | Catechin | Catechin inhibits the reaction [[4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone co-treated with Benzo(a)pyrene] results in increased phosphorylation of H2AFX protein] | 21882252 |
| D000068579 | Celecoxib | Celecoxib inhibits the reaction [Etoposide results in increased phosphorylation of H2AFX protein] | 21745461 |
| D002699 | Chlorambucil | Chlorambucil analog results in increased phosphorylation of H2AFX protein | 16861886 |
| C001599 | chlorite | chlorite promotes the reaction [Bromates results in increased phosphorylation of H2AFX protein] | 21864635 |
| D002737 | Chloroprene | Chloroprene results in increased expression of H2AFX mRNA | 23125180 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased phosphorylation of H2AFX protein | 20548288 |
| C074702 | chromium hexavalent ion | ATR protein affects the reaction [chromium hexavalent ion results in increased phosphorylation of H2AFX protein] | 25288669 |
| C074702 | chromium hexavalent ion | ATR protein affects the reaction [chromium hexavalent ion results in increased ubiquitination of H2AFX protein] | 25288669 |
| C074702 | chromium hexavalent ion | chromium hexavalent ion results in increased phosphorylation of H2AFX protein | 25288669 |
| C074702 | chromium hexavalent ion | chromium hexavalent ion results in increased ubiquitination of H2AFX protein | 25288669 |
| C074702 | chromium hexavalent ion | ATR protein affects the reaction [chromium hexavalent ion results in increased phosphorylation of H2AFX protein] | 25288669 |
| C074702 | chromium hexavalent ion | ATR protein affects the reaction [chromium hexavalent ion results in increased ubiquitination of H2AFX protein] | 25288669 |
| C074702 | chromium hexavalent ion | chromium hexavalent ion results in increased expression of H2AFX protein | 25352572 |
| C074702 | chromium hexavalent ion | chromium hexavalent ion results in increased phosphorylation of H2AFX protein | 25288669 |
| C074702 | chromium hexavalent ion | chromium hexavalent ion results in increased ubiquitination of H2AFX protein | 25288669 |
| C530333 | cis-diammine(pyridine)chloroplatinum(II) | cis-diammine(pyridine)chloroplatinum(II) results in increased phosphorylation of and results in increased ubiquitination of H2AFX protein | 21750216 |
| D007464 | Clioquinol | Clioquinol results in increased phosphorylation of H2AFX protein | 22627294 |
| C068329 | clofarabine | [clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased expression of H2AFX protein | 20933509 |
| C034456 | CMF regimen | H2AFX mRNA affects the susceptibility to CMF regimen | 18925433 |
| C018021 | cobaltous chloride | Acetylcysteine inhibits the reaction [cobaltous chloride promotes the reaction [nickel chloride results in increased phosphorylation of H2AFX protein]] | 22172632 |
| C018021 | cobaltous chloride | Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of H2AFX protein] | 22172632 |
| C018021 | cobaltous chloride | Acetylcysteine inhibits the reaction [nickel chloride promotes the reaction [cobaltous chloride results in increased phosphorylation of H2AFX protein]] | 22172632 |
| C018021 | cobaltous chloride | cobaltous chloride promotes the reaction [nickel chloride results in increased phosphorylation of H2AFX protein] | 22172632 |
| C018021 | cobaltous chloride | cobaltous chloride results in decreased expression of H2AFX mRNA | 19376846 |
| C018021 | cobaltous chloride | cobaltous chloride results in increased phosphorylation of H2AFX protein | 22172632 |
| C018021 | cobaltous chloride | nickel chloride promotes the reaction [cobaltous chloride results in increased phosphorylation of H2AFX protein] | 22172632 |
| C018021 | cobaltous chloride | cobaltous chloride results in decreased expression of H2AFX mRNA | 24386269 |
| D003300 | Copper | "[Copper binds to phthalic acid binds to 1,10-phenanthroline] which results in increased expression of H2AFX protein modified form" | 22659117 |
| D003300 | Copper | "[Copper binds to phthalic acid binds to 2,2'-Dipyridyl] which results in increased expression of H2AFX protein modified form" | 22659117 |
| C464760 | copper-1,10-phenanthroline | "copper-1,10-phenanthroline results in increased expression of H2AFX protein modified form" | 24638265 |
| D019327 | Copper Sulfate | Copper Sulfate results in decreased expression of H2AFX mRNA | 19549813 |
| D003375 | Coumestrol | "[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of H2AFX mRNA" | 19167446 |
| D003375 | Coumestrol | [Coumestrol co-treated with resveratrol] results in increased expression of H2AFX mRNA | 19167446 |
| D003375 | Coumestrol | Coumestrol results in increased expression of H2AFX mRNA | 19167446 |
| D003375 | Coumestrol | Coumestrol results in increased expression of H2AFX protein modified form | 28986287 |
| C408982 | CPG-oligonucleotide | CPG-oligonucleotide results in decreased expression of H2AFX mRNA | 21878529 |
| C408982 | CPG-oligonucleotide | CPG-oligonucleotide results in decreased expression of H2AFX mRNA | 21878529 |
| C408982 | CPG-oligonucleotide | CPG-oligonucleotide results in increased expression of H2AFX mRNA | 21878529 |
| C029892 | cupric chloride | cupric chloride results in increased phosphorylation of H2AFX protein | 20435356 |
| C030973 | cupric oxide | cupric oxide analog results in increased expression of H2AFX protein | 27270449 |
| C030973 | cupric oxide | cupric oxide results in decreased expression of H2AFX mRNA | 22077320 |
| D003474 | Curcumin | [Curcumin co-treated with Metribolone] results in increased phosphorylation of H2AFX protein | 21134073 |
| D003474 | Curcumin | Curcumin results in increased phosphorylation of H2AFX protein | 19401701|2113407 |
| D003474 | Curcumin | [Isoflavones co-treated with Curcumin] results in increased phosphorylation of H2AFX protein | 21134073 |
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of H2AFX mRNA | 20106945|2163298 |
| C037304 | cyhalothrin | [fludioxonil co-treated with cyprodinil co-treated with procymidone co-treated with iprodione co-treated with cyhalothrin] results in increased phosphorylation of H2AFX protein | 22389207 |
| C108338 | cyprodinil | cyprodinil results in increased phosphorylation of H2AFX protein | 22389207 |
| C108338 | cyprodinil | [fludioxonil co-treated with cyprodinil co-treated with procymidone co-treated with iprodione co-treated with cyhalothrin] results in increased phosphorylation of H2AFX protein | 22389207 |
| D003561 | Cytarabine | Cytarabine results in increased phosphorylation of H2AFX protein | 19628630 |
| C515055 | darinaparsin | darinaparsin results in increased phosphorylation of H2AFX protein | 22535156 |
| D003630 | Daunorubicin | Daunorubicin affects the expression of H2AFX mRNA | 27780733 |
| C014347 | decitabine | ATM protein affects the reaction [decitabine results in increased expression of H2AFX protein] | 17991895 |
| C014347 | decitabine | decitabine affects the localization of H2AFX protein | 17991895 |
| C014347 | decitabine | decitabine results in increased expression of H2AFX protein | 17991895|1822369 |
| C014347 | decitabine | decitabine results in increased phosphorylation of H2AFX protein | 19215824|1973295 |
| C014347 | decitabine | DNMT1 protein affects the reaction [decitabine results in increased expression of H2AFX protein] | 17991895 |
| C014347 | decitabine | pifithrin inhibits the reaction [decitabine results in increased phosphorylation of H2AFX protein] | 19732952 |
| C014347 | decitabine | wortmannin inhibits the reaction [decitabine results in increased expression of H2AFX protein] | 17991895 |
| D003847 | Deoxyglucose | Deoxyglucose results in decreased expression of H2AFX protein | 23363784 |
| D003907 | Dexamethasone | [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in decreased expression of H2AFX mRNA | 26424790 |
| C539263 | di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone | "di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone affects the expression of H2AFX protein" | 25130544 |
| D016190 | Carboplatin | Carboplatin results in increased expression of H2AFX protein | 22302033 |
| D016190 | Carboplatin | palbociclib inhibits the reaction [Carboplatin results in increased expression of H2AFX protein] | 22302033 |
| C121930 | dibenzo(a,l)pyrene diol epoxide | "dibenzo(a,l)pyrene diol epoxide affects the phosphorylation of H2AFX protein" | 18848825 |
| C121930 | dibenzo(a,l)pyrene diol epoxide | "[Hydrogen Peroxide co-treated with dibenzo(a,l)pyrene diol epoxide] results in increased phosphorylation of H2AFX protein" | 18848825 |
| D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in decreased expression of H2AFX mRNA | 17361019|2126653 |
| D002945 | Cisplatin | Cisplatin results in increased phosphorylation of H2AFX protein | 24743697 |
| D002945 | Cisplatin | arsenic trioxide inhibits the reaction [SHH protein inhibits the reaction [Cisplatin results in increased phosphorylation of H2AFX protein]] | 23861973 |
| D002945 | Cisplatin | BMI1 inhibits the reaction [Cisplatin results in increased phosphorylation of H2AFX protein] | 21445297 |
| D002945 | Cisplatin | BRCA1 mutant form promotes the reaction [RRM2 mutant form promotes the reaction [TP53 mutant form promotes the reaction [Cisplatin results in increased phosphorylation of H2AFX protein]]] | 21875941 |
| D002945 | Cisplatin | Cisplatin results in increased expression of H2AFX mRNA | 27594783 |
| D002945 | Cisplatin | Cisplatin results in increased expression of H2AFX protein | 21500194|2238352 |
| D002945 | Cisplatin | Cisplatin results in increased expression of H2AFX protein modified form | 22659117|2499962 |
| D002945 | Cisplatin | Cisplatin results in increased phosphorylation of and results in increased ubiquitination of H2AFX protein | 21750216 |
| D002945 | Cisplatin | Cisplatin results in increased phosphorylation of H2AFX protein | 20145152|2128535 |
| D002945 | Cisplatin | ERCC1 mutant form inhibits the reaction [RRM2 mutant form promotes the reaction [TP53 mutant form promotes the reaction [Cisplatin results in increased phosphorylation of H2AFX protein]]] | 21875941 |
| D002945 | Cisplatin | ERCC1 mutant form inhibits the reaction [TP53 mutant form promotes the reaction [Cisplatin results in increased phosphorylation of H2AFX protein]] | 21875941 |
| D002945 | Cisplatin | ERCC5 mutant form inhibits the reaction [RRM2 mutant form promotes the reaction [TP53 mutant form promotes the reaction [Cisplatin results in increased phosphorylation of H2AFX protein]]] | 21875941 |
| D002945 | Cisplatin | ERCC6 protein inhibits the reaction [Cisplatin results in increased phosphorylation of H2AFX protein] | 21324906 |
| D002945 | Cisplatin | H2AFX gene mutant form inhibits the reaction [MIR138-1 results in increased susceptibility to Cisplatin] | 21693595 |
| D002945 | Cisplatin | Lovastatin inhibits the reaction [Cisplatin results in increased phosphorylation of H2AFX protein] | 21356574 |
| D002945 | Cisplatin | [MIR138-1 results in decreased expression of H2AFX] which results in increased susceptibility to Cisplatin | 21693595 |
| D002945 | Cisplatin | MIR630 mRNA inhibits the reaction [Cisplatin results in increased phosphorylation of H2AFX protein] | 20145152 |
| D002945 | Cisplatin | [Proadifen co-treated with Cisplatin] results in increased phosphorylation of H2AFX protein | 26721606 |
| D002945 | Cisplatin | Quercetin inhibits the reaction [Cisplatin results in increased expression of H2AFX protein modified form] | 24999622 |
| D002945 | Cisplatin | RRM2 mutant form promotes the reaction [TP53 mutant form promotes the reaction [Cisplatin results in increased phosphorylation of H2AFX protein]] | 21875941 |
| D002945 | Cisplatin | S100A11 mutant form promotes the reaction [Cisplatin results in increased expression of H2AFX protein] | 25940438 |
| D002945 | Cisplatin | SHH protein inhibits the reaction [Cisplatin results in increased phosphorylation of H2AFX protein] | 23861973 |
| D002945 | Cisplatin | TP53 mutant form promotes the reaction [Cisplatin results in increased phosphorylation of H2AFX protein] | 21875941 |
| D002945 | Cisplatin | Triiodothyronine analog promotes the reaction [Cisplatin results in increased expression of H2AFX protein] | 22383522 |
| D002945 | Cisplatin | XPA mutant form inhibits the reaction [RRM2 mutant form promotes the reaction [TP53 mutant form promotes the reaction [Cisplatin results in increased phosphorylation of H2AFX protein]]] | 21875941 |
| D002945 | Cisplatin | Cisplatin results in increased expression of H2AFX protein | 26723870 |
| D002945 | Cisplatin | Cisplatin results in increased expression of H2AFX protein modified form | 26739623 |
| D002945 | Cisplatin | Cisplatin results in increased phosphorylation of H2AFX protein | 21285353|2159348 |
| D002945 | Cisplatin | erdosteine inhibits the reaction [Cisplatin results in increased phosphorylation of H2AFX protein] | 26193055 |
| D002945 | Cisplatin | Lovastatin inhibits the reaction [Cisplatin results in increased expression of H2AFX protein modified form] | 26739623 |
| D002945 | Cisplatin | PRKDC protein mutant form promotes the reaction [Cisplatin results in increased phosphorylation of H2AFX protein] | 21324906 |
| D002945 | Cisplatin | Cisplatin results in increased expression of H2AFX protein modified form | 26739623 |
| D002945 | Cisplatin | Lovastatin inhibits the reaction [Cisplatin results in increased expression of H2AFX protein modified form] | 26739623 |
| D004041 | Dietary Fats | Dietary Fats results in decreased expression of H2AFX mRNA | 25016146 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of H2AFX protein modified form | 27746196 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of H2AFX protein | 26589970 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of H2AFX mRNA | 15890375 |
| D002117 | Calcitriol | Calcitriol results in decreased expression of H2AFX mRNA | 21592394 |
| D002117 | Calcitriol | [Testosterone co-treated with Calcitriol] results in decreased expression of H2AFX mRNA | 21592394 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "9,10-Dimethyl-1,2-benzanthracene results in increased expression of H2AFX protein" | 25448685 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "A gene mutant form affects the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of H2AFX protein]" | 25448685 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "9,10-Dimethyl-1,2-benzanthracene results in increased expression of H2AFX protein" | 23969067 |
| D004126 | Dimethylformamide | Dimethylformamide results in increased expression of H2AFX protein | 26387567 |
| D004128 | Dimethylnitrosamine | Dimethylnitrosamine results in increased expression of H2AFX mRNA | 15890375 |
| C024629 | dimethyl phthalate | dimethyl phthalate affects the expression of H2AFX mRNA | 26924002 |
| D004139 | Dinitrofluorobenzene | Dinitrofluorobenzene results in increased expression of H2AFX mRNA | 23999411 |
| D004221 | Disulfiram | Disulfiram inhibits the reaction [propylene dichloride results in increased phosphorylation of H2AFX protein] | 28300663 |
| C067311 | docetaxel | Aphidicolin inhibits the reaction [docetaxel results in increased expression of H2AFX protein] | 20878124 |
| C067311 | docetaxel | docetaxel results in increased expression of H2AFX protein | 20878124 |
| C067311 | docetaxel | wortmannin promotes the reaction [docetaxel results in increased expression of H2AFX protein] | 20878124 |
| D004317 | Doxorubicin | Acetylcysteine inhibits the reaction [Doxorubicin results in increased phosphorylation of H2AFX protein] | 15489221 |
| D004317 | Doxorubicin | Doxorubicin affects the expression of H2AFX mRNA | 27780733 |
| D004317 | Doxorubicin | Doxorubicin inhibits the reaction [palbociclib results in decreased phosphorylation of H2AFX protein] | 22751436 |
| D004317 | Doxorubicin | Doxorubicin promotes the reaction [[CD40LG protein co-treated with IL4 protein] results in increased expression of H2AFX protein modified form] | 27634759 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of H2AFX protein | 22302033 |
| D004317 | Doxorubicin | Doxorubicin results in increased phosphorylation of H2AFX protein | 15489221|1643217 |
| D004317 | Doxorubicin | palbociclib inhibits the reaction [Doxorubicin results in increased expression of H2AFX protein] | 22302033 |
| D004317 | Doxorubicin | shogaol analog inhibits the reaction [Doxorubicin results in increased phosphorylation of H2AFX protein] | 23899529 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of H2AFX protein | 17875725 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of H2AFX protein modified form | 28710503 |
| D004317 | Doxorubicin | Doxorubicin results in increased phosphorylation of H2AFX protein | 22712078 |
| D004317 | Doxorubicin | Lovastatin inhibits the reaction [Doxorubicin results in increased expression of H2AFX protein modified form] | 28710503 |
| D004317 | Doxorubicin | Lovastatin inhibits the reaction [Doxorubicin results in increased phosphorylation of H2AFX protein] | 22712078 |
| D004317 | Doxorubicin | NSC 23766 inhibits the reaction [Doxorubicin results in increased expression of H2AFX protein modified form] | 28710503 |
| D004317 | Doxorubicin | TOP2B protein affects the reaction [Doxorubicin results in increased expression of H2AFX protein] | 17875725 |
| D004317 | Doxorubicin | "4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione inhibits the reaction [Doxorubicin results in increased expression of H2AFX protein]" | 17875725 |
| D004317 | Doxorubicin | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Doxorubicin results in increased expression of H2AFX protein] | 17875725 |
| D004317 | Doxorubicin | Bortezomib inhibits the reaction [Doxorubicin results in increased expression of H2AFX protein] | 17875725 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of H2AFX protein | 17875725 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of H2AFX protein modified form | 24902966 |
| D004317 | Doxorubicin | Quercetin inhibits the reaction [Doxorubicin results in increased expression of H2AFX protein modified form] | 24902966 |
| D004317 | Doxorubicin | Razoxane inhibits the reaction [Doxorubicin results in increased expression of H2AFX protein] | 17875725 |
| C561944 | EMD 534085 | EMD 534085 results in increased expression of H2AFX protein modified form | 18451153 |
| D004642 | Emodin | Emodin results in increased expression of H2AFX protein modified form | 20855424 |
| D004642 | Emodin | TOP2A affects the reaction [Emodin results in increased expression of H2AFX protein modified form] | 20855424 |
| D004809 | Ephedrine | [Caffeine co-treated with Ephedrine] results in increased phosphorylation of H2AFX protein | 15537744 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate inhibits the reaction [epigallocatechin gallate results in increased phosphorylation of H2AFX protein] | 25528115 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate results in increased expression of H2AFX protein | 25585349|2917557 |
| C045651 | epigallocatechin gallate | epigallocatechin gallate results in increased phosphorylation of H2AFX protein | 25528115 |
| C093787 | epothilone A | [epothilone A co-treated with Metformin] results in increased expression of H2AFX mRNA | 29117515 |
| C093787 | epothilone A | epothilone A results in increased expression of H2AFX mRNA | 29117515 |
| C048498 | erdosteine | erdosteine inhibits the reaction [Cisplatin results in increased phosphorylation of H2AFX protein] | 26193055 |
| D000069347 | Erlotinib Hydrochloride | Erlotinib Hydrochloride promotes the reaction [resveratrol results in increased expression of H2AFX protein modified form] | 25895606 |
| D000069347 | Erlotinib Hydrochloride | Erlotinib Hydrochloride results in increased expression of H2AFX protein modified form | 25895606 |
| D000069347 | Erlotinib Hydrochloride | resveratrol promotes the reaction [Erlotinib Hydrochloride results in increased expression of H2AFX protein modified form] | 25895606 |
| C007366 | erythritol anhydride | Acetylcysteine inhibits the reaction [erythritol anhydride results in increased expression of H2AFX protein modified form] | 25633853 |
| C007366 | erythritol anhydride | erythritol anhydride results in increased expression of H2AFX protein modified form | 25633853 |
| C007633 | estragole | estragole results in increased expression of H2AFX protein modified form | 29054680 |
| D000431 | Ethanol | Ethanol results in decreased expression of H2AFX mRNA | 24355176 |
| D000431 | Ethanol | Ethanol results in increased phosphorylation of H2AFX protein | 24374569 |
| D000431 | Ethanol | BRCA1 gene mutant form promotes the reaction [Ethanol results in increased phosphorylation of H2AFX protein] | 26629949 |
| D000431 | Ethanol | [BRCA1 gene mutant form results in increased susceptibility to Ethanol] which results in increased phosphorylation of H2AFX protein | 26629949 |
| D000431 | Ethanol | Ethanol results in increased phosphorylation of H2AFX protein | 26629949 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of H2AFX mRNA | 12072388 |
| D005047 | Etoposide | Etoposide results in increased phosphorylation of H2AFX protein | 24743697 |
| D005047 | Etoposide | Celecoxib inhibits the reaction [Etoposide results in increased phosphorylation of H2AFX protein] | 21745461 |
| D005047 | Etoposide | Etoposide results in increased expression of H2AFX protein | 22302033|2625960 |
| D005047 | Etoposide | Etoposide results in increased phosphorylation of H2AFX protein | 20978201|2174546 |
| D005047 | Etoposide | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Etoposide results in increased phosphorylation of H2AFX protein] | 21745461 |
| D005047 | Etoposide | nimesulide inhibits the reaction [Etoposide results in increased phosphorylation of H2AFX protein] | 21745461 |
| D005047 | Etoposide | palbociclib inhibits the reaction [Etoposide results in increased expression of H2AFX protein] | 22302033 |
| D005047 | Etoposide | pifithrin promotes the reaction [Etoposide results in increased expression of H2AFX protein] | 26259609 |
| D005047 | Etoposide | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Etoposide results in increased expression of H2AFX protein] | 20643100 |
| D005047 | Etoposide | Etoposide results in increased expression of H2AFX protein | 17875725|2064310 |
| D005047 | Etoposide | H2AFX protein results in decreased susceptibility to Etoposide | 21555580 |
| D005047 | Etoposide | TOP2B protein affects the reaction [Etoposide results in increased expression of H2AFX protein] | 17875725 |
| D005047 | Etoposide | "4,4'-(1,2-dimethyl-1,2-ethanediyl)bis-2,6-piperazinedione inhibits the reaction [Etoposide results in increased expression of H2AFX protein]" | 17875725 |
| D005047 | Etoposide | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Etoposide results in increased expression of H2AFX protein] | 17875725 |
| D005047 | Etoposide | Bortezomib inhibits the reaction [Etoposide results in increased expression of H2AFX protein] | 17875725 |
| D005047 | Etoposide | Etoposide results in increased expression of H2AFX protein | 17875725 |
| D005047 | Etoposide | Razoxane inhibits the reaction [Etoposide results in increased expression of H2AFX protein] | 17875725 |
| D015025 | Zearalenone | Zearalenone results in increased expression of H2AFX protein modified form | 28089945|2855277 |
| C000499 | ferric oxide | ferric oxide analog results in increased expression of H2AFX protein | 27270449 |
| C000499 | ferric oxide | Oxygen deficiency inhibits the reaction [ferric oxide analog results in increased expression of H2AFX protein] | 27270449 |
| C020748 | ferrous sulfate | 2-tert-butylhydroquinone inhibits the reaction [ferrous sulfate results in increased expression of H2AFX protein] | 28583816 |
| C020748 | ferrous sulfate | ferrous sulfate results in increased expression of H2AFX protein | 28583816 |
| D044950 | Flavanones | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one promotes the reaction [Flavanones results in increased phosphorylation of H2AFX protein] | 21616090 |
| D044950 | Flavanones | CDKN1A gene mutant form promotes the reaction [Flavanones results in increased phosphorylation of H2AFX protein] | 21616090 |
| D044950 | Flavanones | Flavanones results in increased phosphorylation of H2AFX protein | 21616090 |
| D044950 | Flavanones | PI103 promotes the reaction [Flavanones results in increased phosphorylation of H2AFX protein] | 21616090 |
| D044950 | Flavanones | TP53 gene mutant form promotes the reaction [Flavanones results in increased phosphorylation of H2AFX protein] | 21616090 |
| D044950 | Flavanones | U 0126 promotes the reaction [Flavanones results in increased phosphorylation of H2AFX protein] | 21616090 |
| C024352 | fludarabine | Acetylcysteine inhibits the reaction [[fludarabine co-treated with LAQ824] results in increased expression of H2AFX protein] | 18852132 |
| C024352 | fludarabine | [clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased expression of H2AFX protein | 20933509 |
| C024352 | fludarabine | [fludarabine co-treated with LAQ824] results in increased expression of H2AFX protein | 18852132 |
| C024352 | fludarabine | fludarabine results in increased expression of H2AFX protein | 18852132 |
| C024352 | fludarabine | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [[fludarabine co-treated with LAQ824] results in increased expression of H2AFX protein] | 18852132 |
| C108339 | fludioxonil | [fludioxonil co-treated with cyprodinil co-treated with procymidone co-treated with iprodione co-treated with cyhalothrin] results in increased phosphorylation of H2AFX protein | 22389207 |
| C108339 | fludioxonil | fludioxonil results in increased phosphorylation of H2AFX protein | 22389207 |
| C007738 | fluoranthene | [1-methylanthracene co-treated with fluoranthene] results in decreased expression of H2AFX mRNA | 28329830 |
| D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene results in increased expression of H2AFX protein | 26338220 |
| D005472 | Fluorouracil | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Fluorouracil co-treated with olaparib] results in increased phosphorylation of H2AFX protein] | 26544897 |
| D005472 | Fluorouracil | Fluorouracil affects the expression of H2AFX mRNA | 16584549 |
| D005472 | Fluorouracil | [Fluorouracil co-treated with olaparib] results in increased phosphorylation of H2AFX protein | 26544897 |
| D005472 | Fluorouracil | Fluorouracil results in increased phosphorylation of H2AFX protein | 26544897 |
| D005472 | Fluorouracil | [S100A11 mutant form results in increased susceptibility to Fluorouracil] which results in increased expression of H2AFX protein | 25940438 |
| D005472 | Fluorouracil | TP53 gene mutant form affects the reaction [benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Fluorouracil co-treated with olaparib] results in increased phosphorylation of H2AFX protein]] | 26544897 |
| D005472 | Fluorouracil | TP53 protein affects the reaction [Fluorouracil results in decreased expression of H2AFX mRNA] | 15016801 |
| D005485 | Flutamide | Flutamide results in increased expression of H2AFX mRNA | 24793618 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased phosphorylation of H2AFX protein | 20548288 |
| C010238 | fomepizole | fomepizole inhibits the reaction [propylene dichloride results in increased phosphorylation of H2AFX protein] | 28300663 |
| C054368 | fotemustine | fotemustine results in increased expression of H2AFX protein modified form | 25125662 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [bisphenol A results in increased expression of H2AFX protein] | 23788033 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [Estradiol results in increased expression of H2AFX protein] | 23788033 |
| C056933 | fumonisin B1 | fumonisin B1 results in decreased expression of H2AFX protein | 25800559 |
| C039281 | furan | furan results in increased methylation of H2AFX gene | 22079235 |
| D019833 | Genistein | ATM protein affects the reaction [Genistein results in increased phosphorylation of H2AFX protein] | 15177039 |
| D019833 | Genistein | Genistein results in increased expression of H2AFX mRNA | 16474171 |
| D019833 | Genistein | Genistein results in increased phosphorylation of H2AFX protein | 15177039 |
| C023847 | Glu-P-2 | Glu-P-2 results in increased expression of H2AFX protein modified form | 28160022 |
| D005978 | Glutathione | Glutathione inhibits the reaction [2-chloroethyl ethyl sulfide results in increased phosphorylation of H2AFX protein] | 21722719 |
| D006575 | Heterocyclic Compounds, 3-Ring | "Heterocyclic Compounds, 3-Ring results in increased expression of H2AFX protein" | 21500194 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased phosphorylation of H2AFX protein | 18793623|2474369 |
| D006861 | Hydrogen Peroxide | morin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of H2AFX protein] | 18793623 |
| D006861 | Hydrogen Peroxide | Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of H2AFX protein] | 28300663 |
| D006861 | Hydrogen Peroxide | [ERCC6 protein affects the susceptibility to Hydrogen Peroxide] which affects the expression of H2AFX protein | 25136123 |
| D006861 | Hydrogen Peroxide | "[Hydrogen Peroxide co-treated with 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide] results in increased phosphorylation of H2AFX protein" | 18848825 |
| D006861 | Hydrogen Peroxide | "[Hydrogen Peroxide co-treated with dibenzo(a,l)pyrene diol epoxide] results in increased phosphorylation of H2AFX protein" | 18848825 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in decreased expression of H2AFX protein modified form | 27655674 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of H2AFX mRNA | 25972194 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of H2AFX protein | 25972194 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of H2AFX protein modified form | 29074359 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased phosphorylation of H2AFX protein | 28300663 |
| D006861 | Hydrogen Peroxide | MIRLET7G mRNA inhibits the reaction [Hydrogen Peroxide results in increased expression of H2AFX protein] | 25972194 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of H2AFX protein | 17875725 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased expression of H2AFX protein | 17875725 |
| C031927 | hydroquinone | hydroquinone affects the localization of H2AFX protein modified form | 20036648 |
| C031927 | hydroquinone | hydroquinone results in increased expression of H2AFX protein alternative form | 21267443 |
| C031927 | hydroquinone | hydroquinone results in increased phosphorylation of H2AFX protein | 18835433 |
| C031927 | hydroquinone | [POLH mutant form results in increased susceptibility to hydroquinone] which results in increased expression of H2AFX protein | 22981619 |
| C031927 | hydroquinone | WRN gene mutant form promotes the reaction [hydroquinone results in increased expression of H2AFX protein alternative form] | 21267443 |
| C031927 | hydroquinone | WRN protein affects the reaction [hydroquinone results in increased expression of H2AFX protein] | 17875398 |
| D006918 | Hydroxyurea | Hydroxyurea results in increased expression of H2AFX protein | 25130544 |
| D006918 | Hydroxyurea | Hydroxyurea results in increased expression of H2AFX protein modified form | 25125662 |
| D006918 | Hydroxyurea | Hydroxyurea results in increased phosphorylation of H2AFX protein | 29228353 |
| D006918 | Hydroxyurea | TRP53 gene mutant form inhibits the reaction [Hydroxyurea results in increased phosphorylation of H2AFX protein] | 29228353 |
| C492448 | ICG 001 | ICG 001 results in decreased expression of H2AFX mRNA | 26191083 |
| D000068877 | Imatinib Mesylate | Imatinib Mesylate promotes the reaction [ON 01910 results in increased phosphorylation of H2AFX protein] | 26008977 |
| D000068877 | Imatinib Mesylate | Imatinib Mesylate results in increased expression of H2AFX protein | 20028860 |
| D000068877 | Imatinib Mesylate | Imatinib Mesylate results in increased phosphorylation of H2AFX protein | 26008977 |
| D000068877 | Imatinib Mesylate | ON 01910 promotes the reaction [Imatinib Mesylate results in increased phosphorylation of H2AFX protein] | 26008977 |
| C056493 | imiquimod | imiquimod results in decreased expression of H2AFX mRNA | 21878529 |
| C578795 | indimitecan | indimitecan results in increased phosphorylation of H2AFX protein | 21710981 |
| C033148 | iprodione | [fludioxonil co-treated with cyprodinil co-treated with procymidone co-treated with iprodione co-treated with cyhalothrin] results in increased phosphorylation of H2AFX protein | 22389207 |
| C051890 | irinotecan | irinotecan metabolite results in increased expression of H2AFX mRNA | 15956246 |
| C051890 | irinotecan | irinotecan results in increased expression of H2AFX mRNA | 15956246 |
| D017953 | Isocyanates | Isocyanates analog results in increased phosphorylation of H2AFX protein | 19111005 |
| D017953 | Isocyanates | Isocyanates results in increased expression of H2AFX protein | 19283680 |
| D017953 | Isocyanates | [Isocyanates results in increased phosphorylation of ATM protein] which results in increased phosphorylation of H2AFX protein | 19197993 |
| D007529 | Isoflavones | [Isoflavones co-treated with Curcumin] results in increased phosphorylation of H2AFX protein | 21134073 |
| D007545 | Isoproterenol | Isoproterenol results in increased expression of H2AFX mRNA | 21335049 |
| C006552 | kaempferol | kaempferol results in increased phosphorylation of H2AFX protein | 19028473 |
| C006552 | kaempferol | kaempferol results in increased expression of H2AFX protein | 24595819 |
| C477361 | LAQ824 | Acetylcysteine inhibits the reaction [[fludarabine co-treated with LAQ824] results in increased expression of H2AFX protein] | 18852132 |
| C477361 | LAQ824 | Acetylcysteine inhibits the reaction [LAQ824 results in increased expression of H2AFX protein] | 18852132 |
| C477361 | LAQ824 | [fludarabine co-treated with LAQ824] results in increased expression of H2AFX protein | 18852132 |
| C477361 | LAQ824 | LAQ824 results in increased expression of H2AFX protein | 18852132 |
| C477361 | LAQ824 | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [[fludarabine co-treated with LAQ824] results in increased expression of H2AFX protein] | 18852132 |
| C477361 | LAQ824 | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [LAQ824 results in increased expression of H2AFX protein] | 18852132 |
| D007840 | Latex | Latex analog results in increased expression of H2AFX mRNA | 24768652 |
| C045463 | leflunomide | leflunomide results in decreased expression of H2AFX mRNA | 28988120 |
| C038753 | leptomycin B | leptomycin B promotes the reaction [Bortezomib results in increased expression of H2AFX protein modified form] | 16778179 |
| C506643 | liposomal doxorubicin | liposomal doxorubicin results in increased phosphorylation of H2AFX protein | 27923599 |
| D008130 | Lomustine | Lomustine results in increased phosphorylation of H2AFX protein | 24743697 |
| C581034 | longikaurin A | longikaurin A results in increased expression of H2AFX protein modified form | 28801140 |
| D008148 | Lovastatin | Lovastatin inhibits the reaction [Cisplatin results in increased phosphorylation of H2AFX protein] | 21356574 |
| D008148 | Lovastatin | Lovastatin inhibits the reaction [Cisplatin results in increased expression of H2AFX protein modified form] | 26739623 |
| D008148 | Lovastatin | Lovastatin inhibits the reaction [Doxorubicin results in increased expression of H2AFX protein modified form] | 28710503 |
| D008148 | Lovastatin | Lovastatin inhibits the reaction [Doxorubicin results in increased phosphorylation of H2AFX protein] | 22712078 |
| D008148 | Lovastatin | Lovastatin inhibits the reaction [Cisplatin results in increased expression of H2AFX protein modified form] | 26739623 |
| C048341 | mafosfamide | mafosfamide results in increased phosphorylation of H2AFX protein | 24743697 |
| C097284 | manganese(III)-tetrakis(4-benzoic acid)porphyrin | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [[fludarabine co-treated with LAQ824] results in increased expression of H2AFX protein] | 18852132 |
| C097284 | manganese(III)-tetrakis(4-benzoic acid)porphyrin | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [LAQ824 results in increased expression of H2AFX protein] | 18852132 |
| C097284 | manganese(III)-tetrakis(4-benzoic acid)porphyrin | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [resveratrol promotes the reaction [panobinostat results in increased expression of H2AFX protein]] | 22923501 |
| C054474 | manumycin | Acetylcysteine inhibits the reaction [manumycin results in increased phosphorylation of H2AFX protein] | 19409983 |
| C054474 | manumycin | manumycin results in increased phosphorylation of H2AFX protein | 19409983 |
| D008466 | Mechlorethamine | Mechlorethamine results in increased expression of H2AFX protein modified form | 25891025 |
| D008627 | Mercuric Chloride | Mercuric Chloride affects the expression of H2AFX mRNA | 20353558 |
| D008687 | Metformin | [epothilone A co-treated with Metformin] results in increased expression of H2AFX mRNA | 29117515 |
| D008687 | Metformin | Metformin results in decreased expression of H2AFX protein | 23363784 |
| D008687 | Metformin | Metformin results in increased expression of H2AFX mRNA | 29117515 |
| D008701 | Methapyrilene | Methapyrilene results in increased expression of H2AFX mRNA | 15890375 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased phosphorylation of H2AFX protein | 20548288 |
| D008727 | Methotrexate | H2AFX protein affects the susceptibility to Methotrexate | 16217747 |
| D008727 | Methotrexate | Methotrexate results in increased phosphorylation of H2AFX protein | 21114963 |
| D008730 | Methoxsalen | Methoxsalen inhibits the reaction [aflatoxin G1 results in increased expression of H2AFX protein modified form] | 23907605 |
| C005223 | methyleugenol | methyleugenol results in increased expression of H2AFX protein | 26011634 |
| C000614724 | methyleugenol-2',3'-epoxide | "methyleugenol-2',3'-epoxide results in increased expression of H2AFX protein" | 26542539 |
| D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in increased phosphorylation of H2AFX protein | 24743697 |
| D008769 | Methylnitronitrosoguanidine | Methylnitronitrosoguanidine results in increased phosphorylation of H2AFX protein | 24743697 |
| D015655 | 1-Methyl-4-phenylpyridinium | 1-Methyl-4-phenylpyridinium results in decreased expression of H2AFX mRNA | 24810058 |
| D015741 | Metribolone | ATM mutant form inhibits the reaction [Metribolone results in increased expression of H2AFX protein] | 23272087 |
| D015741 | Metribolone | [ATM mutant form inhibits the reaction [Metribolone results in increased expression of H2AFX protein]] which results in increased expression of ERG mRNA | 23272087 |
| D015741 | Metribolone | ATR mutant form inhibits the reaction [Metribolone results in increased expression of H2AFX protein] | 23272087 |
| D015741 | Metribolone | [Curcumin co-treated with Metribolone] results in increased phosphorylation of H2AFX protein | 21134073 |
| D015741 | Metribolone | Metribolone results in increased expression of H2AFX protein | 23272087 |
| D016685 | Mitomycin | Mitomycin results in increased phosphorylation of H2AFX protein | 24743697 |
| D016685 | Mitomycin | Mitomycin results in increased phosphorylation of H2AFX protein | 21386838 |
| D008942 | Mitoxantrone | Mitoxantrone results in increased expression of H2AFX protein | 24994473 |
| C517284 | monomethyl phthalate | monomethyl phthalate affects the expression of H2AFX mRNA | 26924002 |
| C008548 | morin | morin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of H2AFX protein] | 18793623 |
| C568376 | MT19c compound | MT19c compound results in decreased expression of H2AFX mRNA | 21781307 |
| D009151 | Mustard Gas | Mustard Gas results in increased expression of H2AFX protein modified form | 25102026 |
| D009151 | Mustard Gas | Mustard Gas results in increased phosphorylation of H2AFX protein | 20435105|2544827 |
| D009151 | Mustard Gas | pifithrin promotes the reaction [Mustard Gas results in increased phosphorylation of H2AFX protein] | 25448276 |
| C080955 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Etoposide results in increased phosphorylation of H2AFX protein] | 21745461 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in increased expression of H2AFX mRNA" | 25554681 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of H2AFX mRNA" | 25554681 |
| D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate affects the expression of H2AFX protein | 26011634 |
| D009532 | Nickel | Nickel results in increased expression of H2AFX mRNA | 25583101 |
| C119536 | nickel acetate | NFE2L2 protein inhibits the reaction [nickel acetate results in increased expression of H2AFX mRNA] | 23023193 |
| C119536 | nickel acetate | nickel acetate results in decreased expression of H2AFX mRNA | 23023193 |
| C022838 | nickel chloride | Acetylcysteine inhibits the reaction [cobaltous chloride promotes the reaction [nickel chloride results in increased phosphorylation of H2AFX protein]] | 22172632 |
| C022838 | nickel chloride | Acetylcysteine inhibits the reaction [nickel chloride promotes the reaction [cobaltous chloride results in increased phosphorylation of H2AFX protein]] | 22172632 |
| C022838 | nickel chloride | Acetylcysteine inhibits the reaction [nickel chloride results in increased phosphorylation of H2AFX protein] | 22172632 |
| C022838 | nickel chloride | cobaltous chloride promotes the reaction [nickel chloride results in increased phosphorylation of H2AFX protein] | 22172632 |
| C022838 | nickel chloride | nickel chloride promotes the reaction [cobaltous chloride results in increased phosphorylation of H2AFX protein] | 22172632 |
| C022838 | nickel chloride | nickel chloride results in decreased expression of H2AFX mRNA | 17312168 |
| C022838 | nickel chloride | nickel chloride results in increased expression of H2AFX protein modified form | 28552779 |
| C022838 | nickel chloride | nickel chloride results in increased phosphorylation of H2AFX protein | 22172632 |
| C028007 | nickel monoxide | nickel monoxide analog results in increased expression of H2AFX protein | 27270449 |
| C028007 | nickel monoxide | Oxygen deficiency inhibits the reaction [nickel monoxide analog results in increased expression of H2AFX protein] | 27270449 |
| D009538 | Nicotine | Nicotine inhibits the reaction [aflatoxin G1 results in increased expression of H2AFX protein modified form] | 23907605 |
| C012655 | nimesulide | nimesulide inhibits the reaction [Etoposide results in increased phosphorylation of H2AFX protein] | 21745461 |
| D015376 | Nimustine | Nimustine results in increased phosphorylation of H2AFX protein | 26418950 |
| D009588 | Nitrogen Mustard Compounds | MGMT protein affects the reaction [Nitrogen Mustard Compounds results in increased expression of H2AFX protein] | 27342729 |
| D009588 | Nitrogen Mustard Compounds | Nitrogen Mustard Compounds results in decreased expression of and results in increased phosphorylation of H2AFX protein | 27342729 |
| D009588 | Nitrogen Mustard Compounds | Nitrogen Mustard Compounds results in increased expression of H2AFX mRNA | 27342729 |
| D009588 | Nitrogen Mustard Compounds | Nitrogen Mustard Compounds results in increased expression of H2AFX protein | 27342729 |
| D015112 | 4-Nitroquinoline-1-oxide | 4-Nitroquinoline-1-oxide results in increased phosphorylation of H2AFX protein | 24743697 |
| D015739 | Nocodazole | Nocodazole results in increased expression of H2AFX protein modified form | 26914363 |
| D009640 | Norethindrone | Norethindrone results in increased phosphorylation of H2AFX protein | 15905198 |
| C487513 | NSC 23766 | NSC 23766 inhibits the reaction [Doxorubicin results in increased expression of H2AFX protein modified form] | 28710503 |
| C553898 | NSC 724998 | 3-amino-6-(4-(methylsulfonyl)phenyl)-N-phenylpyrazine-2-carboxamide inhibits the reaction [NSC 724998 results in increased expression of H2AFX protein modified form] | 25269479 |
| C553898 | NSC 724998 | NSC 724998 results in increased expression of H2AFX protein modified form | 25269479 |
| C553898 | NSC 724998 | NSC 724998 results in increased phosphorylation of H2AFX protein | 21710981 |
| C025589 | ochratoxin A | ochratoxin A results in decreased expression of H2AFX mRNA | 19287073 |
| C025589 | ochratoxin A | ochratoxin A results in increased expression of H2AFX protein | 28286205 |
| C025589 | ochratoxin A | ochratoxin A results in increased expression of H2AFX mRNA | 23358140 |
| C025589 | ochratoxin A | ochratoxin A results in increased expression of H2AFX protein modified form | 24243707 |
| C531550 | olaparib | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Fluorouracil co-treated with olaparib] results in increased phosphorylation of H2AFX protein] | 26544897 |
| C531550 | olaparib | [Fluorouracil co-treated with olaparib] results in increased phosphorylation of H2AFX protein | 26544897 |
| C531550 | olaparib | TP53 gene mutant form affects the reaction [benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Fluorouracil co-treated with olaparib] results in increased phosphorylation of H2AFX protein]] | 26544897 |
| C507134 | ON 01910 | Imatinib Mesylate promotes the reaction [ON 01910 results in increased phosphorylation of H2AFX protein] | 26008977 |
| C507134 | ON 01910 | ON 01910 promotes the reaction [Imatinib Mesylate results in increased phosphorylation of H2AFX protein] | 26008977 |
| C507134 | ON 01910 | ON 01910 results in increased expression of H2AFX protein | 25316768 |
| C507134 | ON 01910 | ON 01910 results in increased phosphorylation of H2AFX protein | 21646468|2558085 |
| C030110 | oxaliplatin | oxaliplatin results in increased phosphorylation of H2AFX protein | 24743697 |
| C030110 | oxaliplatin | MSH3 protein promotes the reaction [oxaliplatin results in increased phosphorylation of and affects the localization of H2AFX protein] | 21285347 |
| C030110 | oxaliplatin | oxaliplatin affects the localization of H2AFX protein modified form | 19735649 |
| C030110 | oxaliplatin | oxaliplatin results in increased expression of H2AFX protein modified form | 19735649 |
| C030110 | oxaliplatin | oxaliplatin results in increased phosphorylation of and affects the localization of H2AFX protein | 21285347 |
| C030110 | oxaliplatin | oxaliplatin results in increased phosphorylation of and results in increased ubiquitination of H2AFX protein | 21750216 |
| C030110 | oxaliplatin | [pifithrin results in decreased phosphorylation of TP53 protein] inhibits the reaction [oxaliplatin results in increased expression of H2AFX protein modified form] | 19735649 |
| C030110 | oxaliplatin | [oxaliplatin co-treated with Topotecan] results in decreased expression of H2AFX mRNA | 25729387 |
| C552952 | oxazolinodaunorubicin | oxazolinodaunorubicin affects the expression of H2AFX mRNA | 27780733 |
| D010100 | Oxygen | Oxygen deficiency inhibits the reaction [ferric oxide analog results in increased expression of H2AFX protein] | 27270449 |
| D010100 | Oxygen | Oxygen deficiency inhibits the reaction [nickel monoxide analog results in increased expression of H2AFX protein] | 27270449 |
| D010100 | Oxygen | Oxygen deficiency results in decreased expression of H2AFX mRNA | 26516004 |
| D017239 | Paclitaxel | Paclitaxel results in increased expression of H2AFX protein | 22302033 |
| D017239 | Paclitaxel | Paclitaxel results in increased expression of H2AFX protein modified form | 18451153 |
| D017239 | Paclitaxel | palbociclib inhibits the reaction [Paclitaxel results in increased expression of H2AFX protein] | 22302033 |
| C500026 | palbociclib | Doxorubicin inhibits the reaction [palbociclib results in decreased phosphorylation of H2AFX protein] | 22751436 |
| C500026 | palbociclib | palbociclib inhibits the reaction [Camptothecin results in increased expression of H2AFX protein] | 22302033 |
| C500026 | palbociclib | palbociclib inhibits the reaction [Carboplatin results in increased expression of H2AFX protein] | 22302033 |
| C500026 | palbociclib | palbociclib inhibits the reaction [Doxorubicin results in increased expression of H2AFX protein] | 22302033 |
| C500026 | palbociclib | palbociclib inhibits the reaction [Etoposide results in increased expression of H2AFX protein] | 22302033 |
| C500026 | palbociclib | palbociclib inhibits the reaction [Paclitaxel results in increased expression of H2AFX protein] | 22302033 |
| C500026 | palbociclib | palbociclib results in decreased phosphorylation of H2AFX protein | 22751436 |
| C500026 | palbociclib | RB1 protein affects the reaction [palbociclib results in decreased phosphorylation of H2AFX protein] | 22751436 |
| C005413 | palmatine | palmatine results in increased expression of H2AFX protein modified form | 23747414 |
| C496932 | panobinostat | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [resveratrol promotes the reaction [panobinostat results in increased expression of H2AFX protein]] | 22923501 |
| C496932 | panobinostat | panobinostat promotes the reaction [SRT2183 results in increased expression of H2AFX protein modified form] | 23681230 |
| C496932 | panobinostat | panobinostat results in increased expression of H2AFX protein | 22923501 |
| C496932 | panobinostat | resveratrol promotes the reaction [panobinostat results in increased expression of H2AFX protein] | 22923501 |
| D052638 | Particulate Matter | Particulate Matter results in increased expression of H2AFX protein modified form | 25533354 |
| D052638 | Particulate Matter | Particulate Matter results in increased phosphorylation of H2AFX protein | 23159502 |
| C410127 | PCB 180 | Acetylcysteine inhibits the reaction [PCB 180 metabolite results in increased phosphorylation of H2AFX protein] | 26148434 |
| C410127 | PCB 180 | Estradiol promotes the reaction [PCB 180 metabolite results in increased phosphorylation of H2AFX protein] | 26148434 |
| C410127 | PCB 180 | PCB 180 metabolite promotes the reaction [Benzo(a)pyrene results in increased phosphorylation of H2AFX protein] | 26148434 |
| C410127 | PCB 180 | PCB 180 metabolite results in increased phosphorylation of H2AFX protein | 26148434 |
| C410127 | PCB 180 | PCB 180 results in increased phosphorylation of H2AFX protein | 26148434 |
| D010416 | Pentachlorophenol | Pentachlorophenol results in increased expression of H2AFX mRNA | 23892564 |
| D010419 | Pentamidine | Pentamidine affects the localization of H2AFX protein modified form | 20144237 |
| D010634 | Phenobarbital | Phenobarbital affects the expression of H2AFX mRNA | 19159669 |
| D010634 | Phenobarbital | Phenobarbital results in increased expression of H2AFX mRNA | 19363144|2309116 |
| D019800 | Phenol | Phenol affects the localization of H2AFX protein modified form | 20096274 |
| C030090 | phosphoramide mustard | phosphoramide mustard results in increased expression of H2AFX protein | 21439308 |
| C030090 | phosphoramide mustard | phosphoramide mustard results in increased expression of H2AFX protein | 21439308 |
| C030090 | phosphoramide mustard | phosphoramide mustard results in increased phosphorylation of and results in increased expression of H2AFX protein | 25497287 |
| C032279 | phthalic acid | "[Copper binds to phthalic acid binds to 1,10-phenanthroline] which results in increased expression of H2AFX protein modified form" | 22659117 |
| C032279 | phthalic acid | "[Copper binds to phthalic acid binds to 2,2'-Dipyridyl] which results in increased expression of H2AFX protein modified form" | 22659117 |
| D010798 | Phycocyanin | Phycocyanin inhibits the reaction [tributyltin results in increased expression of H2AFX protein modified form] | 26079211 |
| C522973 | PI103 | PI103 promotes the reaction [Flavanones results in increased phosphorylation of H2AFX protein] | 21616090 |
| C121565 | pifithrin | pifithrin inhibits the reaction [decitabine results in increased phosphorylation of H2AFX protein] | 19732952 |
| C121565 | pifithrin | pifithrin promotes the reaction [Etoposide results in increased expression of H2AFX protein] | 26259609 |
| C121565 | pifithrin | pifithrin promotes the reaction [Mustard Gas results in increased phosphorylation of H2AFX protein] | 25448276 |
| C121565 | pifithrin | [pifithrin results in decreased phosphorylation of TP53 protein] inhibits the reaction [oxaliplatin results in increased expression of H2AFX protein modified form] | 19735649 |
| D010882 | Piperonyl Butoxide | Piperonyl Butoxide results in increased expression of H2AFX mRNA | 15890375 |
| C006253 | pirinixic acid | pirinixic acid results in decreased expression of H2AFX mRNA | 17426115 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of H2AFX mRNA | 15890375|1916217 |
| D010894 | Piroxicam | Piroxicam results in decreased expression of H2AFX mRNA | 21858171 |
| D010936 | Plant Extracts | MIR23A promotes the reaction [Plant Extracts results in increased expression of H2AFX protein modified form] | 21750350 |
| D010936 | Plant Extracts | Plant Extracts results in increased expression of H2AFX protein modified form | 21750350 |
| D010936 | Plant Extracts | Plant Extracts results in increased expression of H2AFX protein | 24595819 |
| D028321 | Plant Preparations | Plant Preparations results in increased expression of H2AFX protein modified form | 23747414 |
| D011078 | Polychlorinated Biphenyls | Polychlorinated Biphenyls analog results in increased expression of H2AFX mRNA | 16474171 |
| C060540 | polyhexamethyleneguanidine | polyhexamethyleneguanidine results in decreased expression of H2AFX mRNA | 24583197 |
| C505150 | poly(N-vinylpyrrolidine) | [Silver analog co-treated with poly(N-vinylpyrrolidine)] results in increased expression of H2AFX protein | 26028148 |
| C019536 | potassium bromate | bisphenol A inhibits the reaction [[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] which results in increased expression of H2AFX protein] | 25693136 |
| C019536 | potassium bromate | [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] which results in increased expression of H2AFX protein | 25693136 |
| C019536 | potassium bromate | Azacitidine inhibits the reaction [potassium bromate results in increased phosphorylation of H2AFX protein] | 25015661 |
| C019536 | potassium bromate | potassium bromate results in increased phosphorylation of H2AFX protein | 25015661 |
| C019536 | potassium bromate | trichostatin A inhibits the reaction [potassium bromate results in increased phosphorylation of H2AFX protein] | 25015661 |
| D011205 | Povidone | [Silver co-treated with Povidone] results in increased expression of H2AFX protein modified form | 27387714 |
| D011335 | Proadifen | [Proadifen co-treated with Cisplatin] results in increased phosphorylation of H2AFX protein | 26721606 |
| C035988 | procymidone | [fludioxonil co-treated with cyprodinil co-treated with procymidone co-treated with iprodione co-treated with cyhalothrin] results in increased phosphorylation of H2AFX protein | 22389207 |
| D011398 | Promethazine | Promethazine results in decreased expression of H2AFX protein | 26011634 |
| C045950 | propiconazole | propiconazole results in increased expression of H2AFX mRNA | 19363144|2127805 |
| C004765 | propylene dichloride | 1-aminobenzotriazole inhibits the reaction [propylene dichloride results in increased phosphorylation of H2AFX protein] | 28300663 |
| C004765 | propylene dichloride | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [propylene dichloride results in increased phosphorylation of H2AFX protein] | 28300663 |
| C004765 | propylene dichloride | Acetylcysteine inhibits the reaction [propylene dichloride results in increased phosphorylation of H2AFX protein] | 28300663 |
| C004765 | propylene dichloride | Disulfiram inhibits the reaction [propylene dichloride results in increased phosphorylation of H2AFX protein] | 28300663 |
| C004765 | propylene dichloride | fomepizole inhibits the reaction [propylene dichloride results in increased phosphorylation of H2AFX protein] | 28300663 |
| C004765 | propylene dichloride | propylene dichloride results in increased phosphorylation of H2AFX protein | 28300663 |
| C004765 | propylene dichloride | propylene dichloride results in increased phosphorylation of H2AFX protein | 28300663 |
| D011435 | Propyl Gallate | Propyl Gallate results in decreased phosphorylation of H2AFX protein | 26928355 |
| D011435 | Propyl Gallate | [Propyl Gallate results in decreased phosphorylation of H2AFX protein] inhibits the reaction [Camptothecin results in increased activity of and affects the localization of MDC1 protein] | 26928355 |
| D011441 | Propylthiouracil | Propylthiouracil results in increased expression of H2AFX mRNA | 24780913 |
| D047428 | Protein Kinase Inhibitors | Protein Kinase Inhibitors results in increased phosphorylation of H2AFX protein | 21878655 |
| C107773 | pterostilbene | [resveratrol co-treated with pterostilbene] results in decreased expression of H2AFX protein modified form | 26459286 |
| C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [resveratrol results in increased phosphorylation of H2AFX protein] | 25619392 |
| C031280 | pyrazole | pyrazole results in increased expression of H2AFX mRNA | 17945193 |
| D011739 | Pyrimethamine | Pyrimethamine results in increased phosphorylation of H2AFX protein | 19435820 |
| C009131 | pyrimidin-2-one beta-ribofuranoside | pyrimidin-2-one beta-ribofuranoside results in increased expression of H2AFX protein | 17991895 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Cisplatin results in increased expression of H2AFX protein modified form] | 24999622 |
| D011794 | Quercetin | Quercetin results in increased phosphorylation of H2AFX protein | 15177039 |
| D011794 | Quercetin | Quercetin results in increased expression of H2AFX protein | 24595819 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Doxorubicin results in increased expression of H2AFX protein modified form] | 24902966 |
| C004532 | quinone | quinone results in increased phosphorylation of H2AFX protein | 18835433 |
| D011929 | Razoxane | Razoxane inhibits the reaction [Doxorubicin results in increased expression of H2AFX protein] | 17875725 |
| D011929 | Razoxane | Razoxane inhibits the reaction [Etoposide results in increased expression of H2AFX protein] | 17875725 |
| D017382 | Reactive Oxygen Species | H2AFX protein results in decreased susceptibility to Reactive Oxygen Species | 21555580 |
| C031389 | resorcinol | resorcinol results in increased expression of H2AFX mRNA | 22623647 |
| C059514 | resveratrol | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [resveratrol results in increased phosphorylation of H2AFX protein] | 25619392 |
| C059514 | resveratrol | Caffeine inhibits the reaction [resveratrol results in increased phosphorylation of H2AFX protein] | 15975956 |
| C059514 | resveratrol | [Coumestrol co-treated with resveratrol] results in increased expression of H2AFX mRNA | 19167446 |
| C059514 | resveratrol | Erlotinib Hydrochloride promotes the reaction [resveratrol results in increased expression of H2AFX protein modified form] | 25895606 |
| C059514 | resveratrol | H2AFX protein results in increased susceptibility to resveratrol | 25619392 |
| C059514 | resveratrol | manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [resveratrol promotes the reaction [panobinostat results in increased expression of H2AFX protein]] | 22923501 |
| C059514 | resveratrol | pyrazolanthrone inhibits the reaction [resveratrol results in increased phosphorylation of H2AFX protein] | 25619392 |
| C059514 | resveratrol | [resveratrol co-treated with pterostilbene] results in decreased expression of H2AFX protein modified form | 26459286 |
| C059514 | resveratrol | resveratrol promotes the reaction [Erlotinib Hydrochloride results in increased expression of H2AFX protein modified form] | 25895606 |
| C059514 | resveratrol | resveratrol promotes the reaction [panobinostat results in increased expression of H2AFX protein] | 22923501 |
| C059514 | resveratrol | resveratrol promotes the reaction [vorinostat results in increased expression of H2AFX protein] | 22923501 |
| C059514 | resveratrol | resveratrol results in decreased expression of H2AFX protein | 23363784 |
| C059514 | resveratrol | resveratrol results in decreased expression of H2AFX protein modified form | 26459286 |
| C059514 | resveratrol | [resveratrol results in increased activity of [ATM protein co-treated with ATR protein]] which results in increased phosphorylation of H2AFX protein | 15975956 |
| C059514 | resveratrol | resveratrol results in increased expression of H2AFX protein | 22923501 |
| C059514 | resveratrol | resveratrol results in increased expression of H2AFX protein modified form | 23681230|2589560 |
| C059514 | resveratrol | resveratrol results in increased phosphorylation of H2AFX protein | 15975956|1955972 |
| C059514 | resveratrol | [temozolomide co-treated with resveratrol] results in increased phosphorylation of H2AFX protein | 23522185 |
| D015474 | Isotretinoin | Isotretinoin results in decreased expression of H2AFX mRNA | 20436886 |
| D012176 | Retinoids | Retinoids analog results in increased phosphorylation of H2AFX protein | 17512204 |
| C547185 | riccardin D | Caffeine inhibits the reaction [riccardin D results in increased phosphorylation of H2AFX protein] | 24069304 |
| C547185 | riccardin D | riccardin D results in decreased expression of H2AFX mRNA | 24069304 |
| C547185 | riccardin D | riccardin D results in increased phosphorylation of H2AFX protein | 24069304 |
| C087123 | romidepsin | Acetylcysteine inhibits the reaction [[Bortezomib co-treated with romidepsin] results in increased phosphorylation of H2AFX protein] | 15173094 |
| C087123 | romidepsin | [Bortezomib co-treated with romidepsin] results in increased phosphorylation of H2AFX protein | 15173094 |
| D012402 | Rotenone | CASP1 gene mutant form inhibits the reaction [Rotenone results in increased phosphorylation of H2AFX protein] | 23619996 |
| D012402 | Rotenone | H2AFX protein results in decreased susceptibility to Rotenone | 21555580 |
| D012402 | Rotenone | NLRP3 gene mutant form inhibits the reaction [Rotenone results in increased phosphorylation of H2AFX protein] | 23619996 |
| D012402 | Rotenone | Rotenone results in increased phosphorylation of H2AFX protein | 23619996 |
| C028268 | satratoxin G | satratoxin G results in increased activity of H2AFX protein | 20150440 |
| C014184 | satratoxin H | satratoxin H results in increased phosphorylation of H2AFX protein | 22863859 |
| D012643 | Selenium | Selenium results in increased expression of H2AFX mRNA | 19244175 |
| C078903 | seocalcitol | seocalcitol results in decreased expression of H2AFX mRNA | 12040012 |
| C040115 | shogaol | shogaol analog inhibits the reaction [Doxorubicin results in increased phosphorylation of H2AFX protein] | 23899529 |
| D012822 | Silicon Dioxide | PARP1 protein inhibits the reaction [Silicon Dioxide results in increased expression of H2AFX protein modified form] | 28757444 |
| D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of H2AFX mRNA | 25351596 |
| D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of H2AFX protein modified form | 28757444 |
| D012822 | Silicon Dioxide | Silicon Dioxide results in increased phosphorylation of H2AFX protein | 23619996 |
| D012822 | Silicon Dioxide | Silicon Dioxide results in increased phosphorylation of H2AFX protein | 23178243 |
| D012834 | Silver | [Silver analog co-treated with poly(N-vinylpyrrolidine)] results in increased expression of H2AFX protein | 26028148 |
| D012834 | Silver | [Silver co-treated with Povidone] results in increased expression of H2AFX protein modified form | 27387714 |
| C440975 | silybin | Caffeine inhibits the reaction [silybin results in increased phosphorylation of H2AFX protein] | 16777994 |
| C440975 | silybin | silybin results in increased phosphorylation of H2AFX protein | 16777994 |
| D019821 | Simvastatin | Simvastatin results in increased phosphorylation of H2AFX protein | 20499237 |
| D020123 | Sirolimus | Sirolimus results in decreased expression of H2AFX protein | 23363784 |
| C009277 | sodium arsenate | sodium arsenate results in increased expression of H2AFX mRNA | 23922661 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of H2AFX mRNA | 28595984 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of H2AFX protein | 22706169|2486629 |
| C017947 | sodium arsenite | sodium arsenite results in increased phosphorylation of H2AFX protein | 20375080 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of H2AFX protein | 24866292 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of H2AFX mRNA | 16014739 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of H2AFX protein modified form | 25787150 |
| C028982 | sodium chromate(VI) | MUS81 protein mutant form inhibits the reaction [sodium chromate(VI) results in increased expression of H2AFX protein modified form] | 28318385 |
| C028982 | sodium chromate(VI) | sodium chromate(VI) results in increased expression of H2AFX protein modified form | 28318385 |
| D012969 | Sodium Fluoride | Sodium Fluoride results in decreased expression of H2AFX protein | 28918527 |
| D012969 | Sodium Fluoride | Sodium Fluoride results in increased expression of H2AFX protein | 27548804 |
| D012980 | Sodium Salicylate | Sodium Salicylate results in increased expression of H2AFX mRNA | 29117515 |
| D018038 | Sodium Selenite | Sodium Selenite results in increased expression of H2AFX mRNA | 18175754 |
| D012989 | Soil Pollutants | CHEK1 mutant form promotes the reaction [Soil Pollutants results in increased phosphorylation of H2AFX protein] | 22409540 |
| D012989 | Soil Pollutants | Soil Pollutants results in increased phosphorylation of H2AFX protein | 22409540 |
| D012989 | Soil Pollutants | wortmannin promotes the reaction [Soil Pollutants results in increased phosphorylation of H2AFX protein] | 22409540 |
| D053260 | Soot | Soot results in increased expression of H2AFX mRNA | 22461453 |
| D053260 | Soot | Soot results in increased phosphorylation of H2AFX protein | 23178243 |
| C525423 | SRT2183 | panobinostat promotes the reaction [SRT2183 results in increased expression of H2AFX protein modified form] | 23681230 |
| C525423 | SRT2183 | SRT2183 results in increased expression of H2AFX protein modified form | 23681230 |
| D013241 | Sterigmatocystin | Sterigmatocystin results in increased expression of H2AFX protein modified form | 26914363 |
| D013467 | Sulindac | Acetylcysteine inhibits the reaction [Sulindac promotes the reaction [Bortezomib results in increased phosphorylation of H2AFX protein]] | 16033843 |
| D013467 | Sulindac | alpha-Tocopherol inhibits the reaction [Sulindac promotes the reaction [Bortezomib results in increased phosphorylation of H2AFX protein]] | 16033843 |
| D013467 | Sulindac | Sulindac promotes the reaction [Bortezomib results in increased phosphorylation of H2AFX protein] | 16033843 |
| D013467 | Sulindac | [arsenic trioxide co-treated with Sulindac] results in increased phosphorylation of H2AFX protein | 18636201 |
| C473643 | sulphoraphene | sulphoraphene results in increased expression of H2AFX protein | 28346727 |
| D014284 | Triiodothyronine | Triiodothyronine analog promotes the reaction [Cisplatin results in increased expression of H2AFX protein] | 22383522 |
| D014284 | Triiodothyronine | Triiodothyronine analog results in increased phosphorylation of H2AFX protein | 22383522 |
| D013605 | T-2 Toxin | 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [T-2 Toxin results in increased activity of H2AFX protein] | 20150440 |
| D013605 | T-2 Toxin | T-2 Toxin results in increased activity of H2AFX protein | 20150440 |
| C047246 | temozolomide | temozolomide results in increased phosphorylation of H2AFX protein | 24743697 |
| C047246 | temozolomide | [temozolomide co-treated with resveratrol] results in increased phosphorylation of H2AFX protein | 23522185 |
| C047246 | temozolomide | temozolomide results in increased phosphorylation of H2AFX protein | 23522185|2641895 |
| C047246 | temozolomide | H2AFX protein results in decreased susceptibility to temozolomide | 21555580 |
| C003959 | TEMPO | TEMPO results in increased expression of H2AFX protein | 25882087 |
| D013739 | Testosterone | [Testosterone co-treated with Calcitriol] results in decreased expression of H2AFX mRNA | 21592394 |
| D013739 | Testosterone | Testosterone results in decreased expression of H2AFX mRNA | 21592394 |
| D013739 | Testosterone | [bisphenol A co-treated with Testosterone] results in increased expression of H2AFX mRNA | 26496021 |
| C000591600 | tetrachlorobenzoquinone | RAD51 protein inhibits the reaction [tetrachlorobenzoquinone results in increased expression of H2AFX protein modified form] | 27989139 |
| C000591600 | tetrachlorobenzoquinone | tetrachlorobenzoquinone results in increased expression of H2AFX protein modified form | 27989139 |
| C000591600 | tetrachlorobenzoquinone | TP53 protein promotes the reaction [tetrachlorobenzoquinone results in increased expression of H2AFX protein modified form] | 27989139 |
| D013749 | Tetrachlorodibenzodioxin | NFE2L2 gene mutant form promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of H2AFX protein] | 21846477 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of H2AFX mRNA | 21570461 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin promotes the reaction [NFE2L2 gene mutant form results in increased expression of H2AFX protein] | 21846477 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of H2AFX protein | 21846477 |
| D019284 | Thapsigargin | Thapsigargin results in increased expression of H2AFX mRNA | 19442820 |
| D013853 | Thioacetamide | Thioacetamide results in increased expression of H2AFX protein | 26011634 |
| C009495 | titanium dioxide | titanium dioxide results in increased expression of H2AFX mRNA | 23557971 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution results in increased expression of H2AFX mRNA | 27404394|2786577 |
| D019772 | Topotecan | Topotecan results in increased phosphorylation of H2AFX protein | 24743697 |
| D019772 | Topotecan | Topotecan results in increased phosphorylation of H2AFX protein | 16432175 |
| D019772 | Topotecan | [veliparib co-treated with Topotecan] results in increased expression of H2AFX protein | 21795476 |
| D019772 | Topotecan | APAF1 promotes the reaction [Topotecan results in increased phosphorylation of H2AFX protein] | 19812371 |
| D019772 | Topotecan | Topotecan results in increased phosphorylation of H2AFX protein | 19812371 |
| D019772 | Topotecan | TRP53 inhibits the reaction [Topotecan results in increased phosphorylation of H2AFX protein] | 19812371 |
| D019772 | Topotecan | [oxaliplatin co-treated with Topotecan] results in decreased expression of H2AFX mRNA | 25729387 |
| D014112 | Toxaphene | Toxaphene results in decreased expression of H2AFX mRNA | 23153324 |
| D014118 | Toxins, Biological | "Toxins, Biological affects the expression of H2AFX mRNA" | 19682533 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of H2AFX mRNA | 16249480 |
| C032910 | triadimefon | triadimefon results in increased expression of H2AFX mRNA | 19363144 |
| C011559 | tributyltin | Acetylcysteine inhibits the reaction [tributyltin results in increased expression of H2AFX protein modified form] | 26079211 |
| C011559 | tributyltin | Phycocyanin inhibits the reaction [tributyltin results in increased expression of H2AFX protein modified form] | 26079211 |
| C011559 | tributyltin | tributyltin results in increased expression of H2AFX protein modified form | 26079211 |
| C012589 | trichostatin A | trichostatin A results in increased expression of H2AFX mRNA | 15901671 |
| C012589 | trichostatin A | trichostatin A affects the expression of H2AFX mRNA | 28542535 |
| C012589 | trichostatin A | trichostatin A inhibits the reaction [potassium bromate results in increased phosphorylation of H2AFX protein] | 25015661 |
| C023764 | triciribine | triciribine results in increased expression of H2AFX mRNA | 29117515 |
| C015559 | trimellitic anhydride | trimellitic anhydride results in increased expression of H2AFX mRNA | 19042947 |
| D014303 | Trinitrotoluene | Trinitrotoluene affects the expression of H2AFX mRNA | 21346803 |
| C016805 | tris(1,3-dichloro-2-propyl)phosphate | "tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of H2AFX mRNA" | 26179874 |
| C057693 | troglitazone | troglitazone results in decreased expression of H2AFX mRNA | 19140230 |
| C080163 | trovafloxacin | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[TNF protein co-treated with trovafloxacin] results in increased expression of H2AFX protein modified form] | 25748550 |
| C080163 | trovafloxacin | benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [trovafloxacin results in increased expression of H2AFX protein modified form] | 25748550 |
| C080163 | trovafloxacin | [TNF protein co-treated with trovafloxacin] results in increased expression of H2AFX protein modified form | 25748550 |
| C080163 | trovafloxacin | TNF protein promotes the reaction [trovafloxacin results in increased expression of H2AFX protein modified form] | 25748550 |
| C080163 | trovafloxacin | trovafloxacin results in increased expression of H2AFX protein modified form | 25748550 |
| C080163 | trovafloxacin | trovafloxacin results in increased phosphorylation of H2AFX protein | 24817034 |
| C113580 | U 0126 | U 0126 promotes the reaction [Flavanones results in increased phosphorylation of H2AFX protein] | 21616090 |
| D014527 | Uric Acid | CASP1 gene mutant form inhibits the reaction [Uric Acid results in increased phosphorylation of H2AFX protein] | 23619996 |
| D014527 | Uric Acid | NLRP3 gene mutant form inhibits the reaction [Uric Acid results in increased phosphorylation of H2AFX protein] | 23619996 |
| D014527 | Uric Acid | Uric Acid results in increased phosphorylation of H2AFX protein | 23619996 |
| C073339 | usnic acid | NFE2L2 protein inhibits the reaction [usnic acid results in increased expression of H2AFX protein modified form] | 27369375 |
| C073339 | usnic acid | usnic acid results in increased expression of H2AFX protein modified form | 27369375 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of H2AFX mRNA | 15901671 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of H2AFX mRNA | 25979313 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of H2AFX mRNA | 21427059 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of H2AFX protein | 21708246 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of H2AFX protein | 21708246 |
| D014640 | Vancomycin | Vancomycin results in decreased expression of H2AFX mRNA | 18930951 |
| C521013 | veliparib | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [veliparib promotes the reaction [Camptothecin results in increased expression of H2AFX protein]] | 21227924 |
| C521013 | veliparib | ERCC1 protein promotes the reaction [veliparib promotes the reaction [Camptothecin results in increased expression of H2AFX protein]] | 21227924 |
| C521013 | veliparib | ERCC4 protein promotes the reaction [veliparib promotes the reaction [Camptothecin results in increased expression of H2AFX protein]] | 21227924 |
| C521013 | veliparib | TDP1 protein inhibits the reaction [veliparib promotes the reaction [Camptothecin results in increased expression of H2AFX protein]] | 21227924 |
| C521013 | veliparib | [veliparib co-treated with Topotecan] results in increased expression of H2AFX protein | 21795476 |
| C521013 | veliparib | veliparib inhibits the reaction [PARP1 protein mutant form results in increased expression of H2AFX protein modified form] | 27694308 |
| C521013 | veliparib | veliparib promotes the reaction [Camptothecin results in increased expression of H2AFX protein] | 21227924 |
| C521013 | veliparib | veliparib results in increased expression of H2AFX protein | 21917757 |
| C521013 | veliparib | veliparib results in increased expression of H2AFX protein modified form | 27694308 |
| C521013 | veliparib | [veliparib results in increased expression of PARP1 protein] which results in increased expression of H2AFX protein | 17505006 |
| D002762 | Cholecalciferol | Cholecalciferol results in decreased expression of H2AFX protein | 23363784 |
| D024483 | Vitamin K 3 | [Ascorbic Acid results in increased reduction of Vitamin K 3] which results in increased phosphorylation of H2AFX protein | 19482829 |
| C111237 | vorinostat | resveratrol promotes the reaction [vorinostat results in increased expression of H2AFX protein] | 22923501 |
| C111237 | vorinostat | vorinostat results in increased activity of H2AFX protein | 20460513 |
| C111237 | vorinostat | vorinostat results in increased expression of H2AFX protein | 22923501 |
| C111237 | vorinostat | vorinostat results in increased expression of H2AFX protein modified form | 20679231 |
| C111237 | vorinostat | vorinostat results in increased phosphorylation of H2AFX protein | 20531243 |
| C111237 | vorinostat | [carfilzomib co-treated with vorinostat] results in increased expression of H2AFX protein | 20233973 |
| C009687 | wortmannin | wortmannin inhibits the reaction [decitabine results in increased expression of H2AFX protein] | 17991895 |
| C009687 | wortmannin | wortmannin promotes the reaction [docetaxel results in increased expression of H2AFX protein] | 20878124 |
| C009687 | wortmannin | wortmannin promotes the reaction [Soil Pollutants results in increased phosphorylation of H2AFX protein] | 22409540 |
| C022186 | xanthatin | xanthatin results in increased expression of H2AFX protein modified form | 29074359 |
| D015032 | Zinc | Zinc deficiency results in increased expression of H2AFX mRNA | 18356318 |
| C016837 | zinc chloride | zinc chloride results in increased expression of H2AFX mRNA | 18947441 |
| D015034 | Zinc Oxide | Acetylcysteine inhibits the reaction [Zinc Oxide analog results in increased activity of H2AFX protein] | 24614525 |
| D015034 | Zinc Oxide | Zinc Oxide analog results in increased activity of H2AFX protein | 24614525 |
| C088658 | zoledronic acid | zoledronic acid results in increased expression of H2AFX mRNA | 20977926 |